| 1 | S 90049 | - | - | - | - | [1] 6 6 💬
|
| 2 | S 90049 - F36 | - | - | - | - | [1] 6 6 💬
|
| 3 | S 90049 - F38 | - | - | - | - | [1] 6 6 💬
|
| 4 | S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide | - | - | - | - | [1] 46 46 💬
|
| 5 | S-1226 | - | - | - | - | [1] 299 299 💬
|
| 6 | S-4321 | - | - | - | - | [1] 46 46 💬
|
| 7 | S-606001 | - | - | - | - | [1] 256 256 💬
|
| 8 | S-888711 | - | - | - | - | [1] 63 63 💬
|
| 9 | S-adenosyl-L-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 93 93 💬
|
| 10 | S-Adenosyl-L-methionine (SAMe) | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 94 94 💬
|
| 11 | S-adenosyl-methionine (SAMe) capsules | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 93 93 💬
|
| 12 | S-Ketamin | - | - | - | - | [1] 298 298 💬
|
| 13 | S-ketamine & midazolam | [2] Ketamine Ketamine, Midazolam | [5] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Ketamine hydrochloride
,
Midazolam maleate
,
Ketamine
💬
| [21] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| [27] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 70 70 💬
|
| 14 | S-warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 13 13 💬
|
| 15 | S.c. apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 16 | S.c. injections of bovine intestinal Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 46 46 💬
|
| 17 | S103 cells | - | - | - | - | [1] 13 13 💬
|
| 18 | S16257-2 | - | - | - | - | [1] 57 57 💬
|
| 19 | S16527-2 | - | - | - | - | [1] 57 57 💬
|
| 20 | S38 | - | - | - | - | [1] 96 96 💬
|
| 21 | S78989 | - | - | - | - | [3] 41 41, 50, 56 💬
|
| 22 | S90049 | - | - | - | - | [1] 6 6 💬
|
| 23 | S95011 | - | - | - | - | [1] 53 53 💬
|
| 24 | S95011 concentrate for solution for infusion | - | - | - | - | [1] 53 53 💬
|
| 25 | SA-001 | - | - | - | - | [1] 298 298 💬
|
| 26 | SA001 High dose | - | - | - | - | [1] 53 53 💬
|
| 27 | SA001 Low dose | - | - | - | - | [1] 53 53 💬
|
| 28 | SA001 Mid dose | - | - | - | - | [1] 53 53 💬
|
| 29 | SA237 | - | - | - | - | [1] 13 13 💬
|
| 30 | SABRIL | - | - | - | - | [1] 145 145 💬
|
| 31 | SABRIL 500 mg, granules for oral solution | - | - | - | - | [1] 158 158 💬
|
| 32 | Sabril granules for oral use | - | - | - | - | [1] 145 145 💬
|
| 33 | SABRIL SACHETS | - | - | - | - | [1] 145 145 💬
|
| 34 | Sabrilex | - | - | - | - | [1] 145 145 💬
|
| 35 | Sabril® | - | - | - | - | [1] 145 145 💬
|
| 36 | Saccharomyces Boulardii Oral Tablet | - | - | - | - | [1] 51 51 💬
|
| 37 | Saccharomyces Boulardii Probiotic Supplement | - | - | - | - | [1] 291 291 💬
|
| 38 | Saccharum Lactis | - | - | - | - | [1] 49 49 💬
|
| 39 | Sacral Neuromodulation (SNM) | - | - | - | - | [1] 226 226 💬
|
| 40 | Sacubitril | [1] Sacubitril Sacubitril | [1] Sacubitril
Sacubitril
💬
| [1] MME MME 💬
| [4] Alzheimer disease Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system 💬 | [4] 28 28, 58, 210, 222 💬
|
| 41 | Sacubitril / Valsartan | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬
| [2] AGTR1 AGTR1, MME 💬
| [20] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 28 28 💬
|
| 42 | Sacubitril / Valsartan Oral Tablet [Entresto] | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬
| [2] AGTR1 AGTR1, MME 💬
| [20] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬
|
| 43 | SACUBITRIL VALSARTAN | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬
| [2] AGTR1 AGTR1, MME 💬
| [20] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 44 | Sacubitril/Valsartan | [2] Sacubitril Sacubitril, Valsartan | [2] Valsartan
Valsartan
,
Sacubitril
💬
| [2] AGTR1 AGTR1, MME 💬
| [20] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 💬
|
| 45 | SAD: 30mg WVE-003 | [1] WVE-003 WVE-003 | - | - | - | [1] 8 8 💬
|
| 46 | SAD: 60mg WVE-003 | [1] WVE-003 WVE-003 | - | - | - | [1] 8 8 💬
|
| 47 | SAD: 90mg WVE-003 | [1] WVE-003 WVE-003 | - | - | - | [1] 8 8 💬
|
| 48 | SAF-301 | - | - | - | - | [1] 19 19 💬
|
| 49 | Safety observation | - | - | - | - | [1] 6 6 💬
|
| 50 | Saffron | - | - | - | - | [1] 97 97 💬
|
| 51 | Saffron 100 | - | - | - | - | [1] 97 97 💬
|
| 52 | Saffron 50 | - | - | - | - | [1] 97 97 💬
|
| 53 | Saffron and Chamomile | [1] Chamomile Chamomile | [1] German chamomile flower
German chamomile flower
💬
| - | - | [1] 6 6 💬
|
| 54 | Saffron supplement for IBD | - | - | - | - | [1] 97 97 💬
|
| 55 | Saffron supplementation | - | - | - | - | [1] 301 301 💬
|
| 56 | Safinamida | - | - | - | - | [1] 6 6 💬
|
| 57 | SAFINAMIDE | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬
|
| 58 | Safinamide (as add-on therapy) | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 59 | Safinamide + Levodopa | [2] Levodopa Levodopa, Safinamide | [3] Levodopa
Levodopa
,
Safinamide
,
Safinamide mesylate
💬
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬
| [21] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 60 | Safinamide Mesilate | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 61 | SAFINAMIDE METANSOLFONATO | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬
|
| 62 | Safinamide metansolfonato (12 weeks) | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 63 | SAFINAMIDE METHANESULFONATE | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬
|
| 64 | Safinamide Methanesulfonate 100mg | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 65 | Safinamide Methanesulfonate 150mg | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 66 | Safinamide methansulfonate | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 67 | Safinamide, MAO-B inhibitor | [1] Safinamide Safinamide | [2] Safinamide
Safinamide
,
Safinamide mesylate
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 68 | Safinimide 50-100 mg/day | - | - | - | - | [1] 6 6 💬
|
| 69 | Sage | [1] Sage Sage | - | - | - | [1] 6 6 💬
|
| 70 | Sage leaf | [1] Sage Sage | - | - | - | [1] 6 6 💬
|
| 71 | SAGE-217 | - | - | - | - | [1] 6 6 💬
|
| 72 | SAGE-718 | - | - | - | - | [2] 6 6, 8 💬
|
| 73 | SAIT101 | - | - | - | - | [1] 46 46 💬
|
| 74 | SAIT101 (proposed rituximab biosimilar) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 75 | SAIT101 (rituximab biosimilar) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 76 | Salanersen | - | - | - | - | [1] 3 3 💬
|
| 77 | Salazopyrin EN | - | - | - | - | [2] 46 46, 54 💬
|
| 78 | Salazopyrin EN 500 mg enterotabletter | - | - | - | - | [1] 46 46 💬
|
| 79 | Salazopyrin En-Tabs | - | - | - | - | [2] 46 46, 271 💬
|
| 80 | SALAZOPYRINE | - | - | - | - | [1] 46 46 💬
|
| 81 | Salbutamol | - | - | - | - | [9] 2 2, 3, 11, 85, 86, 228, 256, 299, 340 💬
|
| 82 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet | - | - | - | - | [1] 111 111 💬
|
| 83 | Salbutamol 2mg | - | - | - | - | [1] 111 111 💬
|
| 84 | Salbutamol 4mg | - | - | - | - | [1] 111 111 💬
|
| 85 | Salbutamol 4Mg Tablet | - | - | - | - | [1] 11 11 💬
|
| 86 | Salbutamol Only Product in Oral Dose Form | - | - | - | - | [1] 111 111 💬
|
| 87 | SALBUTAMOL SULFATE | - | - | - | - | [1] 111 111 💬
|
| 88 | SALBUTAMOL SULFATE PH. EUR. | - | - | - | - | [1] 11 11 💬
|
| 89 | Salbutamol WZF 4 mg | - | - | - | - | [1] 11 11 💬
|
| 90 | Salbutamol-ratiopharm® N metered-dose aerosol inhaler | - | - | - | - | [1] 299 299 💬
|
| 91 | Salbutamol-ratiopharm® N metereddose aerosol inhaler | - | - | - | - | [1] 299 299 💬
|
| 92 | Salbutamolo | - | - | - | - | [1] 299 299 💬
|
| 93 | Salicylic acid | [1] Salicylic acid Salicylic acid | [4] Salicylic acid
Salicylic acid
,
Sodium salicylate
,
Choline magnesium trisalicylate
,
Diethylamine salicylate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 97 97 💬
|
| 94 | Saline | - | - | - | - | [12] 2 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
|
| 95 | Saline +5% albumin | - | - | - | - | [1] 97 97 💬
|
| 96 | Saline 0.9% | - | - | - | - | [1] 79 79 💬
|
| 97 | Saline 0.9% inhalation solution | - | - | - | - | [1] 299 299 💬
|
| 98 | Saline 0.9% NaCl | - | - | - | - | [1] 235 235 💬
|
| 99 | Saline injection | - | - | - | - | [1] 113 113 💬
|
| 100 | Saline Intranasal Delivery | - | - | - | - | [1] 6 6 💬
|
| 101 | Saline Nasal Mist | - | - | - | - | [1] 127 127 💬
|
| 102 | Saline solution | - | - | - | - | [3] 2 2, 34, 288 💬
|
| 103 | Saline Solution for Injection | - | - | - | - | [1] 19 19 💬
|
| 104 | Saliva sample | - | - | - | - | [1] 49 49 💬
|
| 105 | Saliva samples | - | - | - | - | [1] 160 160 💬
|
| 106 | Saliva sampling | - | - | - | - | [1] 106 106 💬
|
| 107 | Salivary sample | - | - | - | - | [1] 79 79 💬
|
| 108 | Salmeterol | [1] Salmeterol Salmeterol | [2] Salmeterol xinafoate
Salmeterol xinafoate
,
Salmeterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 109 | Salofalk | - | - | - | - | [2] 96 96, 97 💬
|
| 110 | Salofalk 1000mg Granu-Stix | - | - | - | - | [1] 97 97 💬
|
| 111 | Salofalk 1000mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 112 | Salofalk 3g gastro-resistant prolonged-release granules | - | - | - | - | [1] 97 97 💬
|
| 113 | Salofalk 4g/60ml Klysma | - | - | - | - | [1] 97 97 💬
|
| 114 | Salofalk 500 mg | - | - | - | - | [1] 96 96 💬
|
| 115 | Salofalk Granu-Stix 500 mg | - | - | - | - | [1] 97 97 💬
|
| 116 | Salofalk® 1000mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 117 | Salofalk® 500 mg gastro-resistant tablet | - | - | - | - | [1] 97 97 💬
|
| 118 | Salofalk® 500 mg tablets | - | - | - | - | [1] 97 97 💬
|
| 119 | Salofalk® 500mg | - | - | - | - | [1] 97 97 💬
|
| 120 | Salofalk® 500mg Granu-Stix® | - | - | - | - | [1] 97 97 💬
|
| 121 | Salsalate | [1] Salsalate Salsalate | [1] Salsalate
Salsalate
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 5 5 💬
|
| 122 | Salt with folic acid and iodine | [2] Folic acid Folic acid, Iodine | [3] Folic acid
Folic acid
,
Iodine
,
Folate sodium
💬
| - | - | [1] 118 118 💬
|
| 123 | SAM-e | - | - | - | - | [1] 6 6 💬
|
| 124 | Sample collection | - | - | - | - | [1] 222 222 💬
|
| 125 | Sample collection of exfoliated buccal mucosa | - | - | - | - | [1] 6 6 💬
|
| 126 | Sampling | - | - | - | - | [1] 97 97 💬
|
| 127 | Sampling of blood | - | - | - | - | [2] 46 46, 107 💬
|
| 128 | Samsca | - | - | - | - | [2] 67 67, 72 💬
|
| 129 | Samsca 15 mg tablets | - | - | - | - | [1] 67 67 💬
|
| 130 | Samsca 30 mg tablets | - | - | - | - | [1] 67 67 💬
|
| 131 | SAMSCA 7.5 mg oral tablet | - | - | - | - | [1] 67 67 💬
|
| 132 | SAMSCA*10CPR 15MG | - | - | - | - | [1] 72 72 💬
|
| 133 | SAN-300 0.5 mg/kg QW | - | - | - | - | [1] 46 46 💬
|
| 134 | SAN-300 1.0 mg/kg QW | - | - | - | - | [1] 46 46 💬
|
| 135 | SAN-300 2.0 mg/kg QOW | - | - | - | - | [1] 46 46 💬
|
| 136 | SAN-300 4.0 mg/kg QOW | - | - | - | - | [1] 46 46 💬
|
| 137 | SAN-300 4.0 mg/kg QW | - | - | - | - | [1] 46 46 💬
|
| 138 | Sandimmum | - | - | - | - | [1] 97 97 💬
|
| 139 | Sandimmun | - | - | - | - | [2] 97 97, 226 💬
|
| 140 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1] 97 97 💬
|
| 141 | Sandimmun Neoral | - | - | - | - | [5] 54 54, 60, 97, 222, 226 💬
|
| 142 | SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE | - | - | - | - | [1] 60 60 💬
|
| 143 | SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE | - | - | - | - | [1] 60 60 💬
|
| 144 | SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE | - | - | - | - | [1] 60 60 💬
|
| 145 | SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE | - | - | - | - | [1] 60 60 💬
|
| 146 | SANDIMMUN NEORAL*30CPS 100MG | - | - | - | - | [1] 46 46 💬
|
| 147 | SANDIMMUN NEORAL*50CPS 25MG | - | - | - | - | [1] 46 46 💬
|
| 148 | Sandimmun Optoral | - | - | - | - | [2] 53 53, 113 💬
|
| 149 | Sandimmune Neoral | - | - | - | - | [1] 60 60 💬
|
| 150 | SANDINUM | - | - | - | - | [1] 97 97 💬
|
| 151 | Sandostatin | - | - | - | - | [1] 77 77 💬
|
| 152 | Sandostatin (Octreotide Acetate) | [2] Acetate Acetate, Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 153 | Sandostatin LAR | - | - | - | - | [5] 67 67, 77, 84, 193, 227 💬
|
| 154 | SANDOSTATIN LAR 10 mg polvo para suspensión inyectable | - | - | - | - | [1] 77 77 💬
|
| 155 | Sandostatin LAR 10mg | - | - | - | - | [1] 77 77 💬
|
| 156 | Sandostatin LAR 20 mg | - | - | - | - | [1] 227 227 💬
|
| 157 | SANDOSTATIN LAR 20 mg polvo para suspensión inyectable | - | - | - | - | [1] 77 77 💬
|
| 158 | Sandostatin LAR 20mg | - | - | - | - | [1] 77 77 💬
|
| 159 | Sandostatin LAR 20mg, 30mg | - | - | - | - | [1] 77 77 💬
|
| 160 | SANDOSTATIN LAR 30 mg polvo para suspensión inyectable | - | - | - | - | [1] 77 77 💬
|
| 161 | Sandostatin LAR 30mg | - | - | - | - | [1] 77 77 💬
|
| 162 | Sandostatin LAR Depot | - | - | - | - | [1] 77 77 💬
|
| 163 | Sandostatin LAR Depot versus transsphenoidal surgery | - | - | - | - | [1] 77 77 💬
|
| 164 | Sandostatin LAR Injection, 10mg, 20mg, 30mg | - | - | - | - | [1] 77 77 💬
|
| 165 | Sandostatin LAR Monatsdepot 20 mg | - | - | - | - | [1] 77 77 💬
|
| 166 | Sandostatin LAR ® | - | - | - | - | [1] 77 77 💬
|
| 167 | Sandostatin LAR ® (octreotide acetate LAR) 30 MG | [2] Acetate Acetate, Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 168 | Sandostatin LAR, 10 mg, 20 mg and 30 mg | - | - | - | - | [1] 77 77 💬
|
| 169 | Sandostatin LAR-Monatsdepot | - | - | - | - | [1] 77 77 💬
|
| 170 | Sandostatin LAR-Monatsdepot 10 mg | - | - | - | - | [1] 77 77 💬
|
| 171 | Sandostatin LAR-Monatsdepot 20 mg | - | - | - | - | [1] 77 77 💬
|
| 172 | Sandostatin LAR-Monatsdepot 30 mg | - | - | - | - | [1] 77 77 💬
|
| 173 | Sandostatin LAR® | - | - | - | - | [1] 77 77 💬
|
| 174 | Sandostatin ® injection | - | - | - | - | [1] 77 77 💬
|
| 175 | Sandostatina | - | - | - | - | [2] 67 67, 77 💬
|
| 176 | SANDOSTATINA - LAR 10 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE | - | - | - | - | [1] 77 77 💬
|
| 177 | SANDOSTATINA - LAR 10 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 77 77 💬
|
| 178 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [2] 67 67, 77 💬
|
| 179 | SANDOSTATINA - LAR 30 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE | - | - | - | - | [1] 77 77 💬
|
| 180 | SANDOSTATINA - LAR 30 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 77 77 💬
|
| 181 | SANDOSTATINA LAR | - | - | - | - | [2] 67 67, 77 💬
|
| 182 | Sandostatina Lar IM Fl 20mg +2F | - | - | - | - | [1] 67 67 💬
|
| 183 | SANDOSTATINA LAR IM FL 20MG 2F | - | - | - | - | [1] 77 77 💬
|
| 184 | Sandostatine | - | - | - | - | [1] 96 96 💬
|
| 185 | Sandostatine L.P. 10 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM) | - | - | - | - | [1] 77 77 💬
|
| 186 | Sandostatine L.P. 20 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM) | - | - | - | - | [1] 77 77 💬
|
| 187 | Sandostatine L.P. 30 mg, poudre et solvant en seringue | - | - | - | - | [1] 77 77 💬
|
| 188 | Sandostatine L.P. 30 mg, poudre et solvant pour suspension injectable à libération prolongée | - | - | - | - | [1] 77 77 💬
|
| 189 | Sandostatine LAR 20 mg | - | - | - | - | [1] 77 77 💬
|
| 190 | Sandostatine Long Acting Repeatable 30 mg | - | - | - | - | [1] 77 77 💬
|
| 191 | Sandostatin® LAR | - | - | - | - | [1] 77 77 💬
|
| 192 | Sandostatin® LAR®-Monatsdepot 10 mg | - | - | - | - | [1] 77 77 💬
|
| 193 | Sandostatin® LAR®-Monatsdepot 20 mg | - | - | - | - | [1] 77 77 💬
|
| 194 | Sandostatin® LAR®-Monatsdepot 30 mg | - | - | - | - | [1] 77 77 💬
|
| 195 | Sapelizumab (p-INN) | - | - | - | - | [1] 13 13 💬
|
| 196 | SAPHNELO | - | - | - | - | [2] 49 49, 53 💬
|
| 197 | Sapropterin | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [3] 86 86, 124, 240 💬
|
| 198 | Sapropterin (Kuvan) | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 199 | SAPROPTERIN DIHYDROCHLORIDE | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 200 | Sapropterin dihydrochloride (6R-BH4) | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 86 86 💬
|
| 201 | Sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 202 | Sapropterin Dihydrocholoride | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 203 | SAPROPTERIN HYDROCHLORIDE | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 204 | Sapropterin, sapropterin dihydrochloride | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 205 | Sapropterin, sapropterin hydrochloride | [1] Sapropterin Sapropterin | [2] Sapropterin dihydrochloride
Sapropterin dihydrochloride
,
Sapropterin
💬
| - | - | [1] 240 240 💬
|
| 206 | Sapropterindihydrochloride | - | - | - | - | [1] 240 240 💬
|
| 207 | Saproterin dihydrochloride | - | - | - | - | [1] 240 240 💬
|
| 208 | Saquinavir | [1] Saquinavir Saquinavir | [2] Saquinavir
Saquinavir
,
Saquinavir mesylate
💬
| - | - | [4] 86 86, 222, 223, 265 💬
|
| 209 | Saquinavir and ritonavir | [2] Ritonavir Ritonavir, Saquinavir | [3] Ritonavir
Ritonavir
,
Saquinavir
,
Saquinavir mesylate
💬
| - | - | [1] 86 86 💬
|
| 210 | Sar | - | - | - | - | [1] 46 46 💬
|
| 211 | SAR100842 | - | - | - | - | [2] 51 51, 85 💬
|
| 212 | SAR113244 | - | - | - | - | [1] 49 49 💬
|
| 213 | SAR153191 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 271 💬
|
| 214 | SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 💬
|
| 215 | SAR153191-C1F3 drug product | - | - | - | - | [1] 46 46 💬
|
| 216 | SAR153191-P2 drug product | - | - | - | - | [1] 46 46 💬
|
| 217 | SAR153191-P3 drug product | - | - | - | - | [1] 46 46 💬
|
| 218 | SAR156597 | - | - | - | - | [2] 51 51, 85 💬
|
| 219 | SAR231893 | - | - | - | - | [2] 51 51, 160 💬
|
| 220 | SAR236553 | - | - | - | - | [1] 79 79 💬
|
| 221 | SAR236553 (REGN727) | - | - | - | - | [1] 79 79 💬
|
| 222 | SAR236553/REGN727 | - | - | - | - | [1] 79 79 💬
|
| 223 | SAR339375 | - | - | - | - | [1] 218 218 💬
|
| 224 | SAR339658 | - | - | - | - | [2] 13 13, 97 💬
|
| 225 | SAR402671, GZ402671 or GZ / SAR402671 | - | - | - | - | [1] 19 19 💬
|
| 226 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | [3] 6 6, 19, 67 💬
|
| 227 | SAR421869 | [1] SAR421869 SAR421869 | - | - | - | [2] 90 90, 303 💬
|
| 228 | SAR422459 | [1] SAR422459 SAR422459 | - | - | - | [1] 301 301 💬
|
| 229 | SAR439459 | - | - | - | - | [1] 274 274 💬
|
| 230 | SAR441344 | - | - | - | - | [3] 13 13, 49, 53 💬
|
| 231 | SAR441344 IV | - | - | - | - | [2] 13 13, 49 💬
|
| 232 | SAR441344 SC | - | - | - | - | [2] 13 13, 49 💬
|
| 233 | SAR441566 | - | - | - | - | [3] 46 46, 96, 97 💬
|
| 234 | SAR442168 | - | - | - | - | [2] 11 11, 13 💬
|
| 235 | SAR442168Pharmaceutical Form: Film-coated tablet | - | - | - | - | [1] 13 13 💬
|
| 236 | SAR442501 | - | - | - | - | [1] 276 276 💬
|
| 237 | SAR442970 | - | - | - | - | [2] 96 96, 97 💬
|
| 238 | SAR443122 | [1] SAR443122 SAR443122 | [1] Eclitasertib
Eclitasertib
💬
| [1] RIPK1 RIPK1 💬
| [16] Alcoholic liver disease Alcoholic liver disease, Apoptosis, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis C, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Pathogenic Escherichia coli infection, RIG-I-like receptor signaling pathway, Salmonella infection, Shigellosis, TNF signaling pathway, Toll-like receptor signaling pathway 💬 | [1] 97 97 💬
|
| 239 | SAR443820 | - | - | - | - | [2] 2 2, 13 💬
|
| 240 | SAR444671 | - | - | - | - | [3] 61 61, 63, 300 💬
|
| 241 | SAR444836 | - | - | - | - | [1] 240 240 💬
|
| 242 | SAR445088 | - | - | - | - | [2] 14 14, 61 💬
|
| 243 | SAR445088 (BIVV020) | - | - | - | - | [1] 63 63 💬
|
| 244 | SAR445088 (formerly BIVV020) | - | - | - | - | [1] 14 14 💬
|
| 245 | SAR445088 (IV) | - | - | - | - | [1] 14 14 💬
|
| 246 | SAR445088 (SC) | - | - | - | - | [1] 14 14 💬
|
| 247 | SAR445399 | - | - | - | - | [1] 299 299 💬
|
| 248 | SAR445514 | - | - | - | - | [1] 28 28 💬
|
| 249 | SAR446268 | - | - | - | - | [1] 113 113 💬
|
| 250 | SAR447537 | - | - | - | - | [1] 231 231 💬
|
| 251 | SAR448501 | - | - | - | - | [2] 46 46, 49 💬
|
| 252 | SAR650984 | - | - | - | - | [2] 28 28, 61 💬
|
| 253 | Saracatinab | - | - | - | - | [1] 85 85 💬
|
| 254 | Saracatinib | [1] Saracatinib Saracatinib | [1] Saracatinib
Saracatinib
💬
| [2] ABL1 ABL1, SRC 💬
| [50] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [3] 6 6, 89, 272 💬
|
| 255 | SARACATINIB DIFUMARATE | [1] Saracatinib Saracatinib | [1] Saracatinib
Saracatinib
💬
| [2] ABL1 ABL1, SRC 💬
| [50] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human cytomegalovirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 272 272 💬
|
| 256 | SARCLISA | - | - | - | - | [1] 28 28 💬
|
| 257 | Sarcosine | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 💬
|
| 258 | Sarcosine Capsule | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 💬
|
| 259 | Sargramostim | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 💬
|
| 260 | Sargramostim (Leukine) | [1] Sargramostim Sargramostim | [1] Sargramostim
Sargramostim
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 96 96 💬
|
| 261 | SARILUMAB | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 41 41, 46, 84, 107, 271 💬
|
| 262 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA] | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 263 | Sarilumab SAR153191 | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 264 | Sarilumab SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] Sarilumab
Sarilumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 💬
|
| 265 | SarilumabProduct Code: SAR153191 (REGN88)Pharmaceutical Form: Solution for injectionINN or Proposed INN: SARILUMABCurrent Sponsor code: SAR153191Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 175- | - | - | - | - | [1] 107 107 💬
|
| 266 | SARIZOTAN | [1] Sarizotan Sarizotan | [1] Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [2] 6 6, 156 💬
|
| 267 | Sarizotan Cloridrato | [1] Sarizotan Sarizotan | [1] Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 156 156 💬
|
| 268 | Sarizotan HC1 | [1] Sarizotan Sarizotan | [1] Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 269 | Sarizotan HCl | [1] Sarizotan Sarizotan | [1] Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 270 | Sarizotan Hydrochloride | [1] Sarizotan Sarizotan | [1] Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [2] 6 6, 156 💬
|
| 271 | Saroglitazar | [1] Saroglitazar Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
| 272 | SAROGLITAZAR MAGNESIUM | [2] Magnesium Magnesium, Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
| 273 | Saroglitazar Magnesium 1 mg | [2] Magnesium Magnesium, Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
| 274 | Saroglitazar Magnesium 2 mg | [2] Magnesium Magnesium, Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
| 275 | Saroglitazar magnesium 4 mg | [2] Magnesium Magnesium, Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
| 276 | SARS-COV-2 mRNA Vaccine | - | - | - | - | [1] 13 13 💬
|
| 277 | SASS | - | - | - | - | [1] 36 36 💬
|
| 278 | SAT-3247 | - | - | - | - | [1] 113 113 💬
|
| 279 | Satavaptan | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬
|
| 280 | Satavaptan (SR121463) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬
|
| 281 | Satavaptan (SR121463B) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 💬
|
| 282 | Sativex | - | - | - | - | [2] 2 2, 13 💬
|
| 283 | SATIVEX - SPRAY PER MUCOSA ORALE 3 FLACONI NEBULIZZATORI CON POMPA DOSATRICE DA 10 ML - 90 EROGAZIONI | - | - | - | - | [1] 13 13 💬
|
| 284 | Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal | - | - | - | - | [1] 13 13 💬
|
| 285 | Sativex Oromucosal Spray | - | - | - | - | [1] 13 13 💬
|
| 286 | Sativex Oromucosal Spray (non-marketed) | - | - | - | - | [1] 13 13 💬
|
| 287 | Sativex® | - | - | - | - | [1] 13 13 💬
|
| 288 | SATRALIZUMAB | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 11 11, 13, 86, 113 💬
|
| 289 | Satralizumab (120 mg/PFS with NSD) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 290 | Satralizumab (120 mg/vial) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 291 | Satralizumab (120mg/vial) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 292 | Satralizumab (Genetical Recombination) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 86 86 💬
|
| 293 | Satralizumab (r-INN) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 294 | Satralizumab (RO5333787/Enspryng /SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 295 | Satralizumab (RO5333787/Enspryng/SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 296 | Satralizumab (RO5333787/SA237) | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 297 | Satralizumab 120 mg | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 💬
|
| 298 | Satralizumab Prefilled Syringe | [1] Satralizumab Satralizumab | [1] Satralizumab
Satralizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 113 113 💬
|
| 299 | Satrazlizumab (RO5333787/ Enspryng /SA237) | - | - | - | - | [1] 13 13 💬
|
| 300 | Sauerstoff | - | - | - | - | [2] 86 86, 88 💬
|
| 301 | Saxagliptin | [1] Saxagliptin Saxagliptin | [2] Saxagliptin
Saxagliptin
,
Saxagliptin hydrochloride
💬
| [1] DPP4 DPP4 💬
| [2] Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | [1] 299 299 💬
|
| 302 | Saxenda | - | - | - | - | [1] 193 193 💬
|
| 303 | SB 681323 | - | - | - | - | [1] 46 46 💬
|
| 304 | SB-240563 | - | - | - | - | [3] 44 44, 45, 98 💬
|
| 305 | SB-240563 (mepolizumab) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 💬
|
| 306 | SB-318 | - | - | - | - | [1] 19 19 💬
|
| 307 | SB-47171 | - | - | - | - | [1] 19 19 💬
|
| 308 | SB-47898 | - | - | - | - | [1] 19 19 💬
|
| 309 | SB-497115 | - | - | - | - | [1] 63 63 💬
|
| 310 | SB-497115-GR | - | - | - | - | [1] 63 63 💬
|
| 311 | SB-497115-GR 12.5mg | - | - | - | - | [1] 63 63 💬
|
| 312 | SB-497115-GR 25mg | - | - | - | - | [1] 63 63 💬
|
| 313 | SB-497115-GR 50 mg | - | - | - | - | [1] 63 63 💬
|
| 314 | SB-509 | [1] SB-509 SB-509 | - | - | - | [1] 2 2 💬
|
| 315 | SB-656933 | - | - | - | - | [1] 97 97 💬
|
| 316 | SB-656933 Tablets | - | - | - | - | [2] 97 97, 299 💬
|
| 317 | SB-656933-AAA | - | - | - | - | [1] 299 299 💬
|
| 318 | SB-681323 | - | - | - | - | [1] 46 46 💬
|
| 319 | SB-681323 oral tablets | - | - | - | - | [1] 46 46 💬
|
| 320 | SB-681323 Tablets | - | - | - | - | [1] 46 46 💬
|
| 321 | SB-683699 | - | - | - | - | [1] 13 13 💬
|
| 322 | SB-913 | - | - | - | - | [1] 19 19 💬
|
| 323 | SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 324 | SB-FIX | - | - | - | - | [1] 19 19 💬
|
| 325 | SB-IDUA | - | - | - | - | [1] 19 19 💬
|
| 326 | SB012 | - | - | - | - | [1] 97 97 💬
|
| 327 | SB12 (proposed eculizumab biosimilar) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 328 | SB17170 | - | - | - | - | [1] 85 85 💬
|
| 329 | SB2 | - | - | - | - | [1] 46 46 💬
|
| 330 | SB2 (infliximab biosimilar) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 331 | SB2 (proposed biosimilar to infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 332 | SB4 | - | - | - | - | [3] 46 46, 107, 271 💬
|
| 333 | SB4 (etanercept biosimilar) | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 107, 271 💬
|
| 334 | SB4 (proposed biosimilar to etanercept) | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 335 | SB497115 | - | - | - | - | [2] 60 60, 63 💬
|
| 336 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 337 | SB5 (proposed biosimilar to adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 338 | SB656933 | - | - | - | - | [1] 299 299 💬
|
| 339 | SB683699 | - | - | - | - | [1] 13 13 💬
|
| 340 | SBC-102 | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 341 | SBC-102, recombinant human lysosomal acid lipase | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 342 | SBC-103 | - | - | - | - | [1] 19 19 💬
|
| 343 | SBI-087 | - | - | - | - | [2] 46 46, 49 💬
|
| 344 | SBT-020 | - | - | - | - | [1] 8 8 💬
|
| 345 | SBT101 | [1] SBT101 SBT101 | - | - | - | [1] 20 20 💬
|
| 346 | SBT777101 | - | - | - | - | [1] 46 46 💬
|
| 347 | SC belimumab 200 mg | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 348 | SC golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 349 | SC interferon beta-1a | [1] Interferon beta-1a Interferon beta-1a | [1] Interferon beta-1a
Interferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 350 | SC interferon beta-1b | [1] Interferon beta-1b Interferon beta-1b | [1] Interferon beta-1b
Interferon beta-1b
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 351 | SC Investigational Needle Sets | - | - | - | - | [2] 14 14, 65 💬
|
| 352 | SC Peginterferon beta-1a | [1] Peginterferon beta-1a Peginterferon beta-1a | [1] Peginterferon beta-1a
Peginterferon beta-1a
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 💬
|
| 353 | SC therapy | - | - | - | - | [1] 57 57 💬
|
| 354 | SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬
|
| 355 | SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬
|
| 356 | SC Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [2] 96 96, 97 💬
|
| 357 | SC0062 high dose | - | - | - | - | [1] 66 66 💬
|
| 358 | SC0062 low dose | - | - | - | - | [1] 66 66 💬
|
| 359 | SC0062 medium dose | - | - | - | - | [1] 66 66 💬
|
| 360 | SC0062 strength 10mg | - | - | - | - | [1] 66 66 💬
|
| 361 | SC01009 injection | - | - | - | - | [1] 85 85 💬
|
| 362 | SC1011 | - | - | - | - | [1] 85 85 💬
|
| 363 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 364 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 💬
|
| 365 | SC291 | - | - | - | - | [2] 43 43, 49 💬
|
| 366 | ScAAV9.CB.CLN6 | - | - | - | - | [1] 19 19 💬
|
| 367 | ScAAV9.CB.CLN6 (dose: 1.5E14 vector genomes) | - | - | - | - | [1] 19 19 💬
|
| 368 | ScAAV9.U1A.hSGSH | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬
|
| 369 | ScAAV9.U1A.SGSH | - | - | - | - | [1] 19 19 💬
|
| 370 | ScAAV9.U7.ACCA | - | - | - | - | [1] 113 113 💬
|
| 371 | SCENESSE | - | - | - | - | [3] 159 159, 161, 254 💬
|
| 372 | SCH 420814 | - | - | - | - | [1] 6 6 💬
|
| 373 | SCH 420814 10 mg | - | - | - | - | [1] 6 6 💬
|
| 374 | SCH 420814 100 mg | - | - | - | - | [1] 6 6 💬
|
| 375 | SCH 900050 | - | - | - | - | [1] 97 97 💬
|
| 376 | SCH 900259 | - | - | - | - | [1] 46 46 💬
|
| 377 | SCH 900800 | - | - | - | - | [1] 6 6 💬
|
| 378 | SCH-58235 | - | - | - | - | [1] 260 260 💬
|
| 379 | SCH420814 | - | - | - | - | [1] 6 6 💬
|
| 380 | SCH55700 | - | - | - | - | [1] 98 98 💬
|
| 381 | SCH900259 | - | - | - | - | [1] 46 46 💬
|
| 382 | Schisandra chinensis extract | - | - | - | - | [1] 84 84 💬
|
| 383 | Sci-B-Vac | - | - | - | - | [1] 97 97 💬
|
| 384 | SCIO-469 | - | - | - | - | [1] 46 46 💬
|
| 385 | SCLEROLYM | - | - | - | - | [1] 13 13 💬
|
| 386 | Sclerotherapy | - | - | - | - | [1] 227 227 💬
|
| 387 | Sclerotherapy with intralesional bleomycin injection | [1] Bleomycin Bleomycin | [3] Bleomycin sulfate
Bleomycin sulfate
,
Bleomycin hydrochloride
,
Bleomycin
💬
| - | - | [1] 278 278 💬
|
| 388 | SCM-010 | - | - | - | - | [1] 13 13 💬
|
| 389 | Scopolamine | [1] Scopolamine Scopolamine | [2] Scopolamine
Scopolamine
,
Scopolamine hydrobromide
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 390 | Scopolamine, atropine, edaravone and dexmedetomidine | [4] Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | [7] Atropine
Atropine
,
Scopolamine
,
Dexmedetomidine
,
Dexmedetomidine hydrochloride
,
Edaravone
,
Atropine sulfate
,
Scopolamine hydrobromide
💬
| [8] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [16] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|
| 391 | SCRI-CAR19v3 | - | - | - | - | [1] 49 49 💬
|
| 392 | SCRM001_TEVG | - | - | - | - | [1] 210 210 💬
|
| 393 | SCTB35 injection | - | - | - | - | [1] 49 49 💬
|
| 394 | SCTC21C | - | - | - | - | [1] 66 66 💬
|
| 395 | SD-101 | [1] Allantoin Allantoin | [1] Allantoin
Allantoin
💬
| - | - | [1] 36 36 💬
|
| 396 | SD-101 dermal cream (3%) | - | - | - | - | [1] 36 36 💬
|
| 397 | SD-101 Dermal Cream (6%) | - | - | - | - | [1] 36 36 💬
|
| 398 | SD-101-6.0 cream | - | - | - | - | [1] 36 36 💬
|
| 399 | SD-809 | - | - | - | - | [1] 8 8 💬
|
| 400 | SD-QIV | - | - | - | - | [1] 46 46 💬
|
| 401 | SE10599 | - | - | - | - | [1] 299 299 💬
|
| 402 | Seal oil | - | - | - | - | [1] 46 46 💬
|
| 403 | Search for exocrine pancreatic insufficiency at week 0 and 12 | - | - | - | - | [1] 96 96 💬
|
| 404 | Seasonal influenza vaccine | - | - | - | - | [2] 13 13, 46 💬
|
| 405 | Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | - | - | - | - | [1] 84 84 💬
|
| 406 | Seasonal Quadrivalent influenza vaccine | - | - | - | - | [1] 13 13 💬
|
| 407 | Sebelipasa Alfa | - | - | - | - | [1] 19 19 💬
|
| 408 | Sebelipase Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 409 | Sebelipase alfa (SBC-102) | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 410 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 411 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 412 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 413 | Sebetralstat | [1] Sebetralstat Sebetralstat | [1] Sebetralstat
Sebetralstat
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 414 | Second Line ITP agents | - | - | - | - | [1] 63 63 💬
|
| 415 | Second-generation fumaric acid | [1] Fumaric acid Fumaric acid | [1] Fumaric acid
Fumaric acid
💬
| - | - | [1] 13 13 💬
|
| 416 | Secretin | - | - | - | - | [1] 298 298 💬
|
| 417 | Secretin (human synthetic) - ChiRhoClin | - | - | - | - | [1] 298 298 💬
|
| 418 | Secukinmab | - | - | - | - | [1] 46 46 💬
|
| 419 | SECUKINUMAB | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [9] 13 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
|
| 420 | Secukinumab (150 mg) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 421 | Secukinumab (75 mg) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 422 | Secukinumab (AIN457) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 46 46 💬
|
| 423 | Secukinumab (AIN457) 150 mg s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 424 | Secukinumab 150 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 425 | Secukinumab 150 mg (2 injections per dose | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 269 269 💬
|
| 426 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 427 | Secukinumab 150 mg/1 mL Solution for injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 37 37, 271 💬
|
| 428 | Secukinumab 150 mg/ml | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 429 | Secukinumab 150 milligram [Cosentyx] | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 430 | Secukinumab 150mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 💬
|
| 431 | Secukinumab 150mg s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 432 | Secukinumab 300 mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 433 | Secukinumab 300 mg, s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 💬
|
| 434 | Secukinumab 300mg | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 💬
|
| 435 | Secukinumab 300mg s.c. | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 436 | Secukinumab 75 mg/0.5 ml Solution for injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 437 | Secukinumab Injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 160 160 💬
|
| 438 | Secukinumab was administered in a weight-adapted dosing regimen ? Dupilumab was administered at a dose dependent on the patient's weight and age | [2] Dupilumab Dupilumab, Secukinumab | [2] Secukinumab
Secukinumab
,
Dupilumab
💬
| [2] IL17A IL17A, IL4R 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 160 160 💬
|
| 439 | Sedation with IV propofol | [1] Propofol Propofol | [1] Propofol
Propofol
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 6 6 💬
|
| 440 | Sedatives/Hypnotics,Other | - | - | - | - | [1] 107 107 💬
|
| 441 | See below for FCX-007 description) | - | - | - | - | [1] 36 36 💬
|
| 442 | See D.3.9.3 'Other descriptive name' below | - | - | - | - | [1] 46 46 💬
|
| 443 | See Intervention Description) | - | - | - | - | [1] 13 13 💬
|
| 444 | Sefaxersen (RO7434656) | - | - | - | - | [1] 66 66 💬
|
| 445 | SEL-302 | [1] SEL-302 SEL-302 | - | - | - | [1] 246 246 💬
|
| 446 | SELADELPAR | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [2] 93 93, 94 💬
|
| 447 | Seladelpar 10 mg | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 448 | Seladelpar 10 mg Capsule | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 449 | Seladelpar 10 mg or less | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 450 | Seladelpar 5 mg | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 451 | Seladelpar 5 mg Capsule | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 452 | Seladelpar 5-10 mg | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
| 453 | Select DMTs other than ozanimod | [1] Ozanimod Ozanimod | [2] Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 454 | Selective Immunosuppressive agents | - | - | - | - | [1] 96 96 💬
|
| 455 | Selective intensive induction therapy based on ustekinumab clinical decision-making tools | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 💬
|
| 456 | Selective Nerve Root Block | - | - | - | - | [1] 70 70 💬
|
| 457 | Selective Serotonin Uptake Inhibitors (SSRI) | [1] Serotonin Serotonin | - | - | - | [1] 2 2 💬
|
| 458 | SELEGILINE | [1] Selegiline Selegiline | [2] Selegiline hydrochloride
Selegiline hydrochloride
,
Selegiline
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 459 | Selegiline HCl 5 PCH | [1] Selegiline Selegiline | [2] Selegiline hydrochloride
Selegiline hydrochloride
,
Selegiline
💬
| [1] MAOB MAOB 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 460 | Selenium | [1] Selenium Selenium | - | - | - | [5] 13 13, 96, 97, 278, 298 💬
|
| 461 | Selenium supplementation | [1] Selenium Selenium | - | - | - | [1] 97 97 💬
|
| 462 | Selexipag | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 47 47, 51, 70, 84, 86, 88 💬
|
| 463 | Selexipag (Uptravi) | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 464 | Selexipag Film Coated Tablets | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 465 | Selexipag, ACT-293987 (NS-304) | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 466 | Self bone marrow transplant | - | - | - | - | [1] 51 51 💬
|
| 467 | SELG*OS POLV 4BUST 70G 1LT | - | - | - | - | [1] 97 97 💬
|
| 468 | Seliciclib | [1] Seliciclib Seliciclib | - | - | - | [2] 75 75, 299 💬
|
| 469 | Selinexor | [1] Selinexor Selinexor | [1] Selinexor
Selinexor
💬
| [1] XPO1 XPO1 💬
| [5] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Nucleocytoplasmic transport, Ribosome biogenesis in eukaryotes, Viral life cycle - HIV-1 💬 | [1] 28 28 💬
|
| 470 | Selisistat | [1] Selisistat Selisistat | - | - | - | [1] 8 8 💬
|
| 471 | Selonsertib | [1] Selonsertib Selonsertib | [1] Selonsertib
Selonsertib
💬
| [1] MAP3K5 MAP3K5 💬
| [19] Alcoholic liver disease Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬 | [1] 86 86 💬
|
| 472 | Seluang fish oil (Rasbora argyrotaenia) and synbiotic | [1] Fish oil Fish oil | - | - | - | [1] 49 49 💬
|
| 473 | Selumetinib | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 474 | Selumetinib (AZD6244 hyd sulfate) 25mg/m2 | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 475 | Selumetinib (AZD6244 hyd sulfate) 50mg/dose | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 476 | Selumetinib 10mg capsule | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 477 | Selumetinib 25mg capsule | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 478 | Selumetinib capsule formulation | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 479 | Selumetinib capsules 10mg | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 480 | Selumetinib capsules 25mg | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 481 | Selumetinib granule formulation | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 482 | Selumetinib granules in sprinkle capsules for opening 5 mg | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 483 | Selumetinib granules in sprinkle capsules for opening 7.5 mg | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 484 | Selumetinib hyd-sulfate | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 485 | Selumetinib Hyd-sulphate | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 486 | Selumetinib Oral Capsule | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 487 | Selumetinib Sulfate | [1] Selumetinib Selumetinib | [2] Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 488 | Semaglutide | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 6 6, 51, 84, 113, 299 💬
|
| 489 | Semaglutide (Rybelsus®) | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬
|
| 490 | Semaglutide Pen Injector | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 51 51, 84 💬
|
| 491 | Semapimod | [1] Semapimod Semapimod | - | - | - | [1] 96 96 💬
|
| 492 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | [1] 6 6 💬
|
| 493 | Semi-vegetarian diet | - | - | - | - | [1] 97 97 💬
|
| 494 | SEN0014196 | - | - | - | - | [1] 8 8 💬
|
| 495 | SEN0014196 (High Dose) | - | - | - | - | [1] 8 8 💬
|
| 496 | SEN0014196 (Low Dose) | - | - | - | - | [1] 8 8 💬
|
| 497 | Sendoxan | - | - | - | - | [2] 13 13, 43 💬
|
| 498 | Sendoxane | - | - | - | - | [1] 13 13 💬
|
| 499 | Senfrol monotherapy | - | - | - | - | [1] 6 6 💬
|
| 500 | Senicapoc | [1] Senicapoc Senicapoc | [1] Senicapoc
Senicapoc
💬
| [1] KCNN4 KCNN4 💬
| [4] GnRH secretion GnRH secretion, Insulin secretion, Protein digestion and absorption, Salivary secretion 💬 | [1] 85 85 💬
|
| 501 | Senna | - | - | - | - | [1] 291 291 💬
|
| 502 | SEP-363856 | - | - | - | - | [1] 6 6 💬
|
| 503 | Sepiapterin | [1] Sepiapterin Sepiapterin | [1] Sepiapterin
Sepiapterin
💬
| - | - | [1] 240 240 💬
|
| 504 | SEPTRIN | - | - | - | - | [1] 85 85 💬
|
| 505 | Sequential FMT | - | - | - | - | [1] 97 97 💬
|
| 506 | Sequential treatment with rituximab and cladribine | [2] Cladribine Cladribine, Rituximab | [2] Cladribine
Cladribine
,
Rituximab
💬
| [2] MS4A1 MS4A1, RRM1 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Hematopoietic cell lineage, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 507 | SER-214 | - | - | - | - | [1] 6 6 💬
|
| 508 | SER-252 (PEOZ-apomorphine) | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 509 | SER-287 | [1] SER-287 SER-287 | - | - | - | [1] 97 97 💬
|
| 510 | Seralutinib | [1] Seralutinib Seralutinib | [1] Seralutinib
Seralutinib
💬
| [2] PDGFRA PDGFRA, PDGFRB 💬
| [22] Cadherin signaling Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Focal adhesion, Gap junction, Glioma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 86 86 💬
|
| 511 | Seretide | - | - | - | - | [1] 228 228 💬
|
| 512 | Serial night time position splint | - | - | - | - | [1] 51 51 💬
|
| 513 | Sericare | - | - | - | - | [1] 36 36 💬
|
| 514 | Sericare® | - | - | - | - | [1] 36 36 💬
|
| 515 | Serine | [1] Serine Serine | [1] Serine
Serine
💬
| - | - | [5] 2 2, 6, 86, 96, 222 💬
|
| 516 | Serlopitant | [1] Serlopitant Serlopitant | [1] Serlopitant
Serlopitant
💬
| [1] TACR1 TACR1 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 💬
|
| 517 | Serlopitant Tablet | [1] Serlopitant Serlopitant | [1] Serlopitant
Serlopitant
💬
| [1] TACR1 TACR1 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 💬
|
| 518 | Seroquel | - | - | - | - | [1] 6 6 💬
|
| 519 | Serostim®[somatropin (rDNA origin) for injection] | - | - | - | - | [1] 265 265 💬
|
| 520 | Serotonin | [1] Serotonin Serotonin | - | - | - | [2] 2 2, 164 💬
|
| 521 | Sertraline | [1] Sertraline Sertraline | [2] Sertraline hydrochloride
Sertraline hydrochloride
,
Sertraline
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [3] 6 6, 158, 206 💬
|
| 522 | SERUM ALBUMINE 5% | - | - | - | - | [1] 96 96 💬
|
| 523 | Serum and fecal measurements | - | - | - | - | [1] 97 97 💬
|
| 524 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 💬
|
| 525 | Serum containing Avonex | - | - | - | - | [1] 13 13 💬
|
| 526 | Serum Free Avonex | - | - | - | - | [1] 13 13 💬
|
| 527 | Serum physiologique 0.9 % | - | - | - | - | [1] 96 96 💬
|
| 528 | Serum Zn | - | - | - | - | [1] 299 299 💬
|
| 529 | Sesame oil | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬
| - | - | [1] 3 3 💬
|
| 530 | SESAME OIL, REFINED | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬
| - | - | [1] 3 3 💬
|
| 531 | SETANAXIB | [1] Setanaxib Setanaxib | - | - | - | [2] 93 93, 218 💬
|
| 532 | SETANAXIBProduct Code: GKT137831Pharmaceutical Form: Film-coated tabletINN or Proposed INN: SetanaxibCAS Number: 1218942-37-0Current Sponsor code: GKT137831Other descriptive name: GYPP-06 (GKT137831 free base), C10071301-DConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use | - | - | - | - | [1] 93 93 💬
|
| 533 | Setmelanotide | [1] Setmelanotide Setmelanotide | [2] Setmelanotide
Setmelanotide
,
Setmelanotide acetate
💬
| [1] MC4R MC4R 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 134 134, 193, 202, 236, 265 💬
|
| 534 | Seton Placement | - | - | - | - | [1] 96 96 💬
|
| 535 | SETRUSUMAB | [1] Setrusumab Setrusumab | [1] Setrusumab
Setrusumab
💬
| [1] SOST SOST 💬
| [2] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬 | [1] 274 274 💬
|
| 536 | SetrusumabProduct Code: BPS804, UX143Pharmaceutical Form: Lyophilisate for solution for infusionINN or Proposed INN: SETRUSUMABCAS Number: 1847394-95-9Other descriptive name: UX143, BPS804Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 160-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 274 274 💬
|
| 537 | Sevasemten | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 538 | Sevasemten 10 mg | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 539 | Sevasemten 12.5 mg | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 540 | Sevasemten 5 mg | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 541 | Sevasemten Dose 1 | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 542 | Sevasemten Dose 2 | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 543 | Sevasemten Dose 3 | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 544 | Sevasemten Dose 4 | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 545 | Sevasemten Dose 5 | [1] Sevasemten Sevasemten | [1] Sevasemten
Sevasemten
💬
| [8] MYH1 MYH1, MYH13, MYH15, MYH2, MYH3, MYH4, MYH7B, MYH8 💬
| [2] Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 113 113 💬
|
| 546 | Sevelamer | [1] Sevelamer Sevelamer | [3] Sevelamer hydrochloride
Sevelamer hydrochloride
,
Sevelamer carbonate
,
Sevelamer
💬
| - | - | [2] 235 235, 238 💬
|
| 547 | Sevoflurane | [1] Sevoflurane Sevoflurane | [1] Sevoflurane
Sevoflurane
💬
| - | - | [8] 6 6, 21, 22, 34, 70, 98, 225, 296 💬
|
| 548 | Sevoflurane anesthetics | [1] Sevoflurane Sevoflurane | [1] Sevoflurane
Sevoflurane
💬
| - | - | [1] 296 296 💬
|
| 549 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | [1] 96 96 💬
|
| 550 | SF257 C59 | - | - | - | - | [1] 97 97 💬
|
| 551 | SF6 | - | - | - | - | [1] 299 299 💬
|
| 552 | SFA muffin | - | - | - | - | [1] 79 79 💬
|
| 553 | Sfingomielina | - | - | - | - | [1] 79 79 💬
|
| 554 | SG301 SC Injection | - | - | - | - | [1] 49 49 💬
|
| 555 | SG301 Subcutaneous injection | - | - | - | - | [1] 222 222 💬
|
| 556 | SGB-9768 | - | - | - | - | [2] 66 66, 223 💬
|
| 557 | SGLT-2 inhibitor | - | - | - | - | [1] 113 113 💬
|
| 558 | SGLT2 inhibitor | - | - | - | - | [2] 113 113, 218 💬
|
| 559 | SGLT2 inhibitor (Dapagliflozin 10mg) | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [1] 215 215 💬
|
| 560 | SGLT2 inhibitors | - | - | - | - | [3] 208 208, 210, 215 💬
|
| 561 | SGT-001 | - | - | - | - | [1] 113 113 💬
|
| 562 | SGT-003 | - | - | - | - | [1] 113 113 💬
|
| 563 | SH U 555 C | - | - | - | - | [1] 13 13 💬
|
| 564 | Sham | - | - | - | - | [4] 90 90, 211, 301, 303 💬
|
| 565 | Sham acupuncture | - | - | - | - | [1] 97 97 💬
|
| 566 | Sham binder | - | - | - | - | [1] 17 17 💬
|
| 567 | Sham compression | - | - | - | - | [2] 6 6, 17 💬
|
| 568 | Sham control | - | - | - | - | [1] 3 3 💬
|
| 569 | Sham Cystoscopy Procedure | - | - | - | - | [1] 226 226 💬
|
| 570 | Sham DBS | - | - | - | - | [1] 6 6 💬
|
| 571 | Sham Hyperbaric Air | - | - | - | - | [1] 97 97 💬
|
| 572 | Sham Injection | - | - | - | - | [2] 90 90, 302 💬
|
| 573 | Sham Mirror Therapy | - | - | - | - | [1] 149 149 💬
|
| 574 | Sham O2 (medical air) | [1] Medical air Medical air | [1] Air, medical
Air, medical
💬
| - | - | [1] 86 86 💬
|
| 575 | Sham PADN | - | - | - | - | [1] 86 86 💬
|
| 576 | Sham Procedure | - | - | - | - | [3] 3 3, 201, 339 💬
|
| 577 | Sham Resonance Device (Inactive Control) | - | - | - | - | [3] 13 13, 46, 49 💬
|
| 578 | Sham Stimulation | - | - | - | - | [1] 46 46 💬
|
| 579 | Sham Surgery | - | - | - | - | [1] 6 6 💬
|
| 580 | Sham tDCS | - | - | - | - | [1] 6 6 💬
|
| 581 | Sham tPCS | - | - | - | - | [1] 6 6 💬
|
| 582 | Sham Transcranial Direct Current Stimulation | - | - | - | - | [1] 6 6 💬
|
| 583 | Sham Transcranial Direct Current Stimulation (tDCS) | - | - | - | - | [1] 13 13 💬
|
| 584 | Sham ultrasound stimulation (control) | - | - | - | - | [1] 46 46 💬
|
| 585 | Sham vagus nerve stimulation | - | - | - | - | [1] 46 46 💬
|
| 586 | Sham-LP | - | - | - | - | [1] 201 201 💬
|
| 587 | Shenqi Yishen Granules | - | - | - | - | [1] 66 66 💬
|
| 588 | Shenyankangfu tablets | - | - | - | - | [1] 223 223 💬
|
| 589 | Shenyankangfu tablets and Losartan potassium 100mg | [2] Losartan Losartan, Potassium | [3] Losartan potassium
Losartan potassium
,
Losartan
,
Potassium
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 590 | Shenyankangfu tablets and Losartan potassium 50mg | [2] Losartan Losartan, Potassium | [3] Losartan potassium
Losartan potassium
,
Losartan
,
Potassium
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 223 223 💬
|
| 591 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 592 | SHJ002 | - | - | - | - | [1] 53 53 💬
|
| 593 | Short Chain Fatty Acids (SCFA) Dietary Supplement | - | - | - | - | [1] 46 46 💬
|
| 594 | Short-acting Insulin (Actrapid) | - | - | - | - | [1] 299 299 💬
|
| 595 | Short-course Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 596 | Short-Duration Oral Prednisolone with Extended Tapering | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 💬
|
| 597 | Short-term course (12 week) glucocorticoid regimen | - | - | - | - | [1] 222 222 💬
|
| 598 | SHP 655 (BAX 930) | - | - | - | - | [1] 64 64 💬
|
| 599 | SHP611 | - | - | - | - | [1] 19 19 💬
|
| 600 | SHP616 | - | - | - | - | [1] 65 65 💬
|
| 601 | SHP623 | - | - | - | - | [1] 65 65 💬
|
| 602 | SHP643 | - | - | - | - | [1] 65 65 💬
|
| 603 | SHP647 | - | - | - | - | [2] 96 96, 97 💬
|
| 604 | SHP655 | - | - | - | - | [1] 64 64 💬
|
| 605 | SHP675 | - | - | - | - | [1] 19 19 💬
|
| 606 | SHR-1139 Injection | - | - | - | - | [1] 269 269 💬
|
| 607 | SHR-1139 intravenous injection. | - | - | - | - | [1] 97 97 💬
|
| 608 | SHR-1209 | - | - | - | - | [1] 79 79 💬
|
| 609 | SHR-1314 | - | - | - | - | [1] 271 271 💬
|
| 610 | SHR-1703 | - | - | - | - | [1] 44 44 💬
|
| 611 | SHR-1906 | - | - | - | - | [1] 85 85 💬
|
| 612 | SHR-1918 | - | - | - | - | [1] 79 79 💬
|
| 613 | SHR-2010 Injection | - | - | - | - | [1] 66 66 💬
|
| 614 | SHR-2173 | - | - | - | - | [1] 49 49 💬
|
| 615 | SHR-2173 injection | - | - | - | - | [5] 11 11, 49, 63, 66, 222 💬
|
| 616 | SHR-3045 Injection | - | - | - | - | [1] 46 46 💬
|
| 617 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 618 | SHR0302 Tablets | - | - | - | - | [2] 46 46, 97 💬
|
| 619 | SHR1459 High Dose | - | - | - | - | [1] 222 222 💬
|
| 620 | SHR1459 Low Dose | - | - | - | - | [1] 222 222 💬
|
| 621 | SI-722 | - | - | - | - | [1] 226 226 💬
|
| 622 | Sialic acid | - | - | - | - | [1] 30 30 💬
|
| 623 | Sialic acid (INN: aceneuramic acid) | [1] Aceneuramic acid Aceneuramic acid | [1] Aceneuramic acid
Aceneuramic acid
💬
| - | - | [1] 30 30 💬
|
| 624 | Sialic acid, N-acetylneuraminic acid | - | - | - | - | [1] 30 30 💬
|
| 625 | Sialoendoscopy | - | - | - | - | [1] 53 53 💬
|
| 626 | Sibeprenlimab | [1] Sibeprenlimab Sibeprenlimab | [1] Sibeprenlimab
Sibeprenlimab
💬
| [1] TNFSF13 TNFSF13 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬 | [1] 66 66 💬
|
| 627 | Sibofimloc | [1] Sibofimloc Sibofimloc | [1] Sibofimloc
Sibofimloc
💬
| - | - | [1] 96 96 💬
|
| 628 | Sifalimumab | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 629 | Sifalimumab 1,200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 630 | Sifalimumab 200 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 631 | Sifalimumab 600 mg | [1] Sifalimumab Sifalimumab | [1] Sifalimumab
Sifalimumab
💬
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
| [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 💬
|
| 632 | Sifol | - | - | - | - | [1] 6 6 💬
|
| 633 | SIFROL | - | - | - | - | [1] 6 6 💬
|
| 634 | Sifrol 0,088 | - | - | - | - | [1] 6 6 💬
|
| 635 | Sifrol 0,18 | - | - | - | - | [1] 6 6 💬
|
| 636 | Sifrol 0,35 | - | - | - | - | [1] 6 6 💬
|
| 637 | Sifrol 0,7 | - | - | - | - | [1] 6 6 💬
|
| 638 | Sifrol, 0,35 mg Tablette | - | - | - | - | [1] 6 6 💬
|
| 639 | Sifrol, 0,70 mg Tablette | - | - | - | - | [1] 6 6 💬
|
| 640 | Sifrol, Mirapexin | - | - | - | - | [1] 6 6 💬
|
| 641 | Sifrol® | - | - | - | - | [1] 6 6 💬
|
| 642 | Sigmoidoscopy | - | - | - | - | [1] 97 97 💬
|
| 643 | Sigmoidoscopy and biopsy, blood work | - | - | - | - | [1] 97 97 💬
|
| 644 | Sign and symptoms: questionnaire | - | - | - | - | [1] 77 77 💬
|
| 645 | SIGNIFOR | - | - | - | - | [2] 75 75, 77 💬
|
| 646 | SILDENAF | - | - | - | - | [1] 86 86 💬
|
| 647 | Sildenafil | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 648 | Sildenafil (50 mg) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 649 | Sildenafil (Acute-1 hour) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 650 | Sildenafil (as citrate) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 651 | Sildenafil (Revatio) 20 mg TID | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 652 | Sildenafil (Subchronic-4 weeks) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 653 | Sildenafil 10mg oral tablet (participants <20kg), or 20mg oral tablet (participants =20kg) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬
|
| 654 | Sildenafil 20 mg tablets | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 💬
|
| 655 | Sildenafil 20mg | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 656 | Sildenafil 20mg and Bosentan 62.5mg | [2] Bosentan Bosentan, Sildenafil | [4] Bosentan
Bosentan
,
Sildenafil citrate
,
Bosentan
,
Sildenafil
💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 657 | Sildenafil 40mg oral capsule | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 658 | Sildenafil and Losartan | [2] Losartan Losartan, Sildenafil | [4] Losartan potassium
Losartan potassium
,
Sildenafil citrate
,
Losartan
,
Sildenafil
💬
| [2] AGTR1 AGTR1, PDE5A 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 659 | Sildenafil by injection | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬
|
| 660 | Sildenafil citrate | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 💬
|
| 661 | Sildenafil citrate (UK-92,480) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 662 | Sildenafil Filmtabletten | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 663 | Sildenafil Oral Suspension | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 294 294 💬
|
| 664 | Sildenafil singly or in association with Bosentan | [2] Bosentan Bosentan, Sildenafil | [4] Bosentan
Bosentan
,
Sildenafil citrate
,
Bosentan
,
Sildenafil
💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 665 | Sildenafil therapy | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 666 | Sildenafil25 mg | - | - | - | - | [1] 17 17 💬
|
| 667 | SILDENAFILO | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 668 | Silicon | [1] Silicon Silicon | - | - | - | [1] 6 6 💬
|
| 669 | Silikis 3µg/g Salbe | - | - | - | - | [1] 37 37 💬
|
| 670 | Silodosin | [1] Silodosin Silodosin | [1] Silodosin
Silodosin
💬
| [1] ADRA1A ADRA1A 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 6 6, 13 💬
|
| 671 | Silodosin 8 mg | [1] Silodosin Silodosin | [1] Silodosin
Silodosin
💬
| [1] ADRA1A ADRA1A 💬
| [9] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 672 | Silodyx | - | - | - | - | [1] 13 13 💬
|
| 673 | Siltuximab | [1] Siltuximab Siltuximab | [1] Siltuximab
Siltuximab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 28 28, 331 💬
|
| 674 | Silver | [1] Silver Silver | - | - | - | [2] 35 35, 162 💬
|
| 675 | Silycus | - | - | - | - | [1] 75 75 💬
|
| 676 | Silymarin | - | - | - | - | [3] 6 6, 46, 97 💬
|
| 677 | Simethicone | [1] Simethicone Simethicone | [1] Simethicone
Simethicone
💬
| - | - | [2] 13 13, 96 💬
|
| 678 | SimpleCare | - | - | - | - | [1] 36 36 💬
|
| 679 | SimpleJectTM | - | - | - | - | [1] 46 46 💬
|
| 680 | Simplex® Bone Cement | - | - | - | - | [1] 46 46 💬
|
| 681 | SIMPONI | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 682 | Simponi (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 683 | SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE | - | - | - | - | [1] 46 46 💬
|
| 684 | SIMPONI 100 mg | - | - | - | - | [1] 97 97 💬
|
| 685 | SIMPONI 50 mg | - | - | - | - | [1] 97 97 💬
|
| 686 | Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte. | - | - | - | - | [1] 46 46 💬
|
| 687 | SIMPONI 50 mg solución inyectable en pluma precargada | - | - | - | - | [1] 46 46 💬
|
| 688 | Simponi® | - | - | - | - | [3] 46 46, 97, 271 💬
|
| 689 | Simponi® (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 690 | Simtuzimab | - | - | - | - | [1] 94 94 💬
|
| 691 | Simtuzumab | [1] Simtuzumab Simtuzumab | - | - | - | [2] 85 85, 94 💬
|
| 692 | Simulect | - | - | - | - | [3] 66 66, 97, 223 💬
|
| 693 | SimvaHEXAL® 40 mg Filmtabletten | - | - | - | - | [1] 13 13 💬
|
| 694 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [22] 6 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
|
| 695 | Simvastatin 20 mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 46 46 💬
|
| 696 | Simvastatin 20mg/5ml Oral Suspension | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 34 34 💬
|
| 697 | Simvastatin 40 mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 86 86 💬
|
| 698 | Simvastatin 40 mg film-coated tablets | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 699 | Simvastatin 40 mg tablets | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 86 86 💬
|
| 700 | Simvastatin 40mg | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 94 94 💬
|
| 701 | Simvastatin Alternova | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 702 | Simvastatin in relapsing remitting multiple sclerosis | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 703 | Simvastatin Susp. | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 310 310 💬
|
| 704 | Simvastatin therapy | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 57 57 💬
|
| 705 | Simvastatin treatment for 28 days | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 299 299 💬
|
| 706 | Simvastatin-ratiopharm | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬
|
| 707 | Simvastatin-ratiopharm® | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 162 162 💬
|
| 708 | Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 709 | Simvastatine | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [2] 6 6, 13 💬
|
| 710 | Simvastatine Sandoz 40 mg filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 711 | Simvastatine Sandoz 40mg deelbare filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 13 13 💬
|
| 712 | SIN ASIGNAR | - | - | - | - | [1] 299 299 💬
|
| 713 | SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1 | - | - | - | - | [1] 36 36 💬
|
| 714 | SIN RV-mediated COL7A1 corrected autologous skin equivalent | - | - | - | - | [1] 36 36 💬
|
| 715 | SINEMET | - | - | - | - | [1] 6 6 💬
|
| 716 | Sinemet (carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 717 | Sinemet (comparator) | - | - | - | - | [1] 6 6 💬
|
| 718 | Sinemet (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 719 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | - | - | - | - | [1] 6 6 💬
|
| 720 | SINEMET 10-100 | - | - | - | - | [1] 6 6 💬
|
| 721 | SINEMET 100 mg + 25 mg compresse | - | - | - | - | [1] 6 6 💬
|
| 722 | SINEMET 100 mg + 25 mg tablets | - | - | - | - | [1] 6 6 💬
|
| 723 | SINEMET 125 | - | - | - | - | [1] 6 6 💬
|
| 724 | Sinemet 125 mg | - | - | - | - | [1] 6 6 💬
|
| 725 | Sinemet 200mg/50mg | - | - | - | - | [1] 6 6 💬
|
| 726 | SINEMET 25-100 | - | - | - | - | [1] 6 6 💬
|
| 727 | Sinemet 25-100 Oral Tablet | - | - | - | - | [1] 6 6 💬
|
| 728 | SINEMET 25/100 | - | - | - | - | [1] 6 6 💬
|
| 729 | SINEMET CR | - | - | - | - | [1] 6 6 💬
|
| 730 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | - | - | - | - | [1] 6 6 💬
|
| 731 | Sinemet IR | - | - | - | - | [1] 6 6 💬
|
| 732 | SINEMET Plus | - | - | - | - | [1] 6 6 💬
|
| 733 | Sinemet plus (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 734 | Sinemet Plus 25 mg/ 100 mg tablets | - | - | - | - | [1] 6 6 💬
|
| 735 | SINEMET*50CPR 100MG+25MG | - | - | - | - | [1] 6 6 💬
|
| 736 | Sinemet-Plus Tablets | - | - | - | - | [1] 6 6 💬
|
| 737 | Sinemet® | - | - | - | - | [1] 6 6 💬
|
| 738 | Sinemet® 100/25 | - | - | - | - | [1] 6 6 💬
|
| 739 | Sinemet® 100/25 mg | - | - | - | - | [1] 6 6 💬
|
| 740 | Sinemet® controlled release (Carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 741 | Sinemet® CR | - | - | - | - | [1] 6 6 💬
|
| 742 | Sinemet® CR 100/25 | - | - | - | - | [1] 6 6 💬
|
| 743 | SINEMET® Plus 25 mg/100 mg Tablets | - | - | - | - | [1] 6 6 💬
|
| 744 | SINEMET®-Plus Tablets | - | - | - | - | [1] 6 6 💬
|
| 745 | Sinemet®25-100 | - | - | - | - | [1] 6 6 💬
|
| 746 | Single administration of 1x10^8 viable CD4+ CAR+ Foxp3+ cells. | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 747 | Single administration of 3x10^8 viable CD4+ CAR+ Foxp3+ cells. | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 748 | Single Dose | - | - | - | - | [2] 38 38, 162 💬
|
| 749 | Single dose C2N-8E12 | - | - | - | - | [1] 5 5 💬
|
| 750 | Single dose of UC-MSCs | - | - | - | - | [1] 49 49 💬
|
| 751 | Single dose reduced | - | - | - | - | [1] 2 2 💬
|
| 752 | Single dose standard | - | - | - | - | [1] 2 2 💬
|
| 753 | Single dose-group A | - | - | - | - | [1] 97 97 💬
|
| 754 | Single FMT | - | - | - | - | [1] 97 97 💬
|
| 755 | Single in situ intra-arterial injection of bevacizumab | [1] Bevacizumab Bevacizumab | [1] Bevacizumab
Bevacizumab
💬
| [1] VEGFA VEGFA 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 280 280 💬
|
| 756 | Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) | - | - | - | - | [1] 28 28 💬
|
| 757 | Single infusion of Obinutuzumab | [1] Obinutuzumab Obinutuzumab | [1] Obinutuzumab
Obinutuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 758 | Single infusion of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
| 759 | Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy | - | - | - | - | [1] 79 79 💬
|
| 760 | Single Photon Emission Computed Tomography | - | - | - | - | [1] 34 34 💬
|
| 761 | Single subcutaneous injection | - | - | - | - | [1] 235 235 💬
|
| 762 | Single-use autoinjector | - | - | - | - | [1] 13 13 💬
|
| 763 | Single-use autoinjector with a prefilled liquid Avonex syringe | - | - | - | - | [1] 13 13 💬
|
| 764 | Singulair | - | - | - | - | [1] 228 228 💬
|
| 765 | Singulair (Montelukast Sodium) | [1] Montelukast Montelukast | [2] Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| [1] CYSLTR1 CYSLTR1 💬
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 💬
|
| 766 | Sinomenine | [1] Sinomenine Sinomenine | - | - | - | [2] 46 46, 222 💬
|
| 767 | SINVACOR*10MG 20 CPR RIV. | - | - | - | - | [1] 79 79 💬
|
| 768 | SINVACOR*20MG 10 CPR RIV. | - | - | - | - | [1] 79 79 💬
|
| 769 | SINVACOR*28CPR RIV 20MG | - | - | - | - | [1] 51 51 💬
|
| 770 | SINVACOR*40MG 10 CPR RIV. | - | - | - | - | [1] 79 79 💬
|
| 771 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | [1] 13 13 💬
|
| 772 | SION-109 | - | - | - | - | [1] 299 299 💬
|
| 773 | SION-2222 | - | - | - | - | [1] 299 299 💬
|
| 774 | SION-451 | - | - | - | - | [1] 299 299 💬
|
| 775 | SION-719 | - | - | - | - | [1] 299 299 💬
|
| 776 | Siplizumab | [1] Siplizumab Siplizumab | [1] Siplizumab
Siplizumab
💬
| [1] CD2 CD2 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage, IgSF CAM signaling 💬 | [2] 94 94, 95 💬
|
| 777 | Siponimid | - | - | - | - | [1] 50 50 💬
|
| 778 | Siponimob | - | - | - | - | [1] 13 13 💬
|
| 779 | SIPONIMOD | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬
|
| 780 | Siponimod 0,25 mg | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 781 | Siponimod 0.25 mg tablet | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬
|
| 782 | Siponimod 0.5 mg tablet | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬
|
| 783 | Siponimod 1 mg | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 784 | Siponimod 1 mg tablet | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬
|
| 785 | Siponimod 2 mg | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 786 | Siponimod 2 mg tablet | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 💬
|
| 787 | Siponimod fumarato | [1] Siponimod Siponimod | [2] Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 788 | SIPONIMOD FUMARIC ACID | [2] Fumaric acid Fumaric acid, Siponimod | [3] Fumaric acid
Fumaric acid
,
Siponimod fumarate
,
Siponimod
💬
| [2] S1PR1 S1PR1, S1PR5 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 💬
|
| 789 | SIRIO*30CPR EFF 25MG+100MG | - | - | - | - | [1] 6 6 💬
|
| 790 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 791 | Sirolimus (formerly known as Rapamycin) | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 35 35 💬
|
| 792 | Sirolimus (RAPAMUNE) | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 💬
|
| 793 | Sirolimus (Rapamune®) | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 60 60, 278 💬
|
| 794 | Sirolimus (study drug)+ACE inhibitor + statin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 66 66, 223 💬
|
| 795 | Sirolimus 0,1% crème | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 💬
|
| 796 | Sirolimus 0.2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 💬
|
| 797 | Sirolimus 0.4% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 💬
|
| 798 | Sirolimus 1Mg Oral Tablet | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 💬
|
| 799 | Sirolimus 1mg/mL | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 💬
|
| 800 | Sirolimus 2 MG | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 17 17 💬
|
| 801 | Sirolimus 2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 💬
|
| 802 | Sirolimus 2mg | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 💬
|
| 803 | Sirolimus and Hydroxychloroquine 200 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [3] Sirolimus
Sirolimus
,
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 💬
|
| 804 | Sirolimus and Hydroxychloroquine 400 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [3] Sirolimus
Sirolimus
,
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 💬
|
| 805 | Sirolimus Ointment | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 84 84 💬
|
| 806 | Sirolimus Oral Liquid Product 1mg/mL | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 💬
|
| 807 | Sirolimus Oral Product | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 89 89, 158 💬
|
| 808 | Sirolimus, 2% | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 💬
|
| 809 | Sirukumab | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 41 41, 46 💬
|
| 810 | Sirukumab 100 mg | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬
|
| 811 | Sirukumab 50 mg | [1] Sirukumab Sirukumab | [1] Sirukumab
Sirukumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬
|
| 812 | Sitagliptin | [1] Sitagliptin Sitagliptin | [3] Sitagliptin phosphate
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [1] DPP4 DPP4 💬
| [2] Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | [6] 6 6, 63, 75, 77, 233, 299 💬
|
| 813 | Sitagliptin and Metformin | [2] Metformin Metformin, Sitagliptin | [5] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
,
Sitagliptin phosphate
,
Sitagliptin
,
Sitagliptin phosphate
💬
| [3] DPP4 DPP4, PRKAA1, PRKAA2 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, Virion - Hepatitis viruses, mTOR signaling pathway 💬 | [1] 233 233 💬
|
| 814 | Sitaxentan | [1] Sitaxentan Sitaxentan | [2] Sitaxentan
Sitaxentan
,
Sitaxentan sodium
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 815 | Sitaxentan sodium | [1] Sitaxentan Sitaxentan | [2] Sitaxentan
Sitaxentan
,
Sitaxentan sodium
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 816 | Sitaxsentan | [1] Sitaxentan Sitaxentan | [2] Sitaxentan
Sitaxentan
,
Sitaxentan sodium
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 817 | Sitaxsentan alone | - | - | - | - | [1] 86 86 💬
|
| 818 | Sitaxsentan and Sildenafil | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 819 | SITAXSENTAN SODIUM | - | - | - | - | [1] 86 86 💬
|
| 820 | Site specific standard of care comparison | - | - | - | - | [2] 38 38, 39 💬
|
| 821 | SIVASTIN | - | - | - | - | [1] 15 15 💬
|
| 822 | Sivatin 40 mg film-coated tablets | - | - | - | - | [1] 13 13 💬
|
| 823 | Sivelestat | [1] Sivelestat Sivelestat | [1] Sivelestat
Sivelestat
💬
| [1] ELANE ELANE 💬
| [4] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Phagocytosis, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [3] 13 13, 85, 96 💬
|
| 824 | SK&F101468 | - | - | - | - | [1] 6 6 💬
|
| 825 | SK-09 | - | - | - | - | [1] 222 222 💬
|
| 826 | Skeletal survey | - | - | - | - | [1] 19 19 💬
|
| 827 | SKF-101468A | - | - | - | - | [1] 6 6 💬
|
| 828 | SKI-606 | - | - | - | - | [1] 67 67 💬
|
| 829 | SKI-O-703 | - | - | - | - | [2] 46 46, 63 💬
|
| 830 | SKI-O-703 capsule | - | - | - | - | [1] 46 46 💬
|
| 831 | Skin biopsy | - | - | - | - | [6] 6 6, 19, 21, 51, 84, 86 💬
|
| 832 | Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included. | - | - | - | - | [1] 102 102 💬
|
| 833 | Skin punch biopsy | - | - | - | - | [1] 51 51 💬
|
| 834 | Skin-derived ABCB5-positive Mesenchymal Stem cells | [1] Skin-derived ABCB5-positive Mesenchymal Stem cells Skin-derived ABCB5-positive Mesenchymal Stem cells | - | - | - | [1] 36 36 💬
|
| 835 | Skincerity | - | - | - | - | [2] 34 34, 158 💬
|
| 836 | Skincerity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 💬
|
| 837 | Skinercity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 💬
|
| 838 | SKY-0515 | - | - | - | - | [1] 8 8 💬
|
| 839 | SKYCLARYS (omaveloxolone) | [1] Omaveloxolone Omaveloxolone | [1] Omaveloxolone
Omaveloxolone
💬
| [1] NFE2L2 NFE2L2 💬
| [7] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | [1] 18 18 💬
|
| 840 | SL-APO | - | - | - | - | [1] 6 6 💬
|
| 841 | Sleep assessment | - | - | - | - | [1] 13 13 💬
|
| 842 | Sleep parameters | - | - | - | - | [1] 113 113 💬
|
| 843 | SLIT Amikacin | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 844 | Slit Lamp assessment and intra-ocular pressure measurement | - | - | - | - | [1] 19 19 💬
|
| 845 | SLIT(TM) Amikacin | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 846 | SLIT™ Amikacin | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 847 | SLN12140 | - | - | - | - | [2] 62 62, 66 💬
|
| 848 | Slow Dose Titration Group of Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 849 | Slow-tapering glucocorticoids + Inebilizumab | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 850 | SLS-005 | - | - | - | - | [2] 2 2, 18 💬
|
| 851 | SLS-005 Trehalose | [1] Trehalose Trehalose | - | - | - | [1] 2 2 💬
|
| 852 | SLV308 | - | - | - | - | [1] 6 6 💬
|
| 853 | SLV308 (mono) hydro | - | - | - | - | [1] 6 6 💬
|
| 854 | SLV308 (mono) hydrochlo | - | - | - | - | [1] 6 6 💬
|
| 855 | SLV308 (mono) hydrochlori | - | - | - | - | [1] 6 6 💬
|
| 856 | SLV308 (mono) hydrochloride | - | - | - | - | [1] 6 6 💬
|
| 857 | SLV308 (mono)hydrochloride | - | - | - | - | [1] 6 6 💬
|
| 858 | SLV308 hydrochloride | - | - | - | - | [1] 6 6 💬
|
| 859 | SLV308(mono)hydrochloride | - | - | - | - | [1] 6 6 💬
|
| 860 | SLV339 | - | - | - | - | [1] 298 298 💬
|
| 861 | SM03 | - | - | - | - | [1] 46 46 💬
|
| 862 | SM04646 | - | - | - | - | [1] 85 85 💬
|
| 863 | SM101 | - | - | - | - | [3] 49 49, 63, 66 💬
|
| 864 | SM101 20mg/mL | - | - | - | - | [1] 63 63 💬
|
| 865 | SM101 5mg/mL | - | - | - | - | [1] 63 63 💬
|
| 866 | SM17 | - | - | - | - | [1] 97 97 💬
|
| 867 | SM934 | - | - | - | - | [1] 49 49 💬
|
| 868 | Small bowel follow trough | - | - | - | - | [1] 96 96 💬
|
| 869 | Smart plug absorbable lacrimal duct plugs | - | - | - | - | [1] 53 53 💬
|
| 870 | Smartject Device delivery of Golimumab | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 871 | SmartPill Motility System & PillCam Patency Capsule | - | - | - | - | [1] 299 299 💬
|
| 872 | SMderpept | - | - | - | - | [1] 13 13 💬
|
| 873 | SMILAGENIN | [1] Smilagenin Smilagenin | - | - | - | [1] 6 6 💬
|
| 874 | SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML | - | - | - | - | [1] 66 66 💬
|
| 875 | SMOFLipid | - | - | - | - | [1] 96 96 💬
|
| 876 | Smoked Cannabis | - | - | - | - | [1] 13 13 💬
|
| 877 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 💬
|
| 878 | Smoking of cannabis | - | - | - | - | [2] 96 96, 97 💬
|
| 879 | SMP-114 | - | - | - | - | [1] 46 46 💬
|
| 880 | SMS995 | - | - | - | - | [1] 77 77 💬
|
| 881 | SMS995B | - | - | - | - | [1] 77 77 💬
|
| 882 | SMT C1100 | - | - | - | - | [1] 113 113 💬
|
| 883 | SMT C1100 (F5 | - | - | - | - | [1] 113 113 💬
|
| 884 | SMT C1100 (F5) | - | - | - | - | [1] 113 113 💬
|
| 885 | SMT C1100 (F6 | - | - | - | - | [1] 113 113 💬
|
| 886 | SMT C1100 (F6) | - | - | - | - | [1] 113 113 💬
|
| 887 | Snack beverage | - | - | - | - | [1] 299 299 💬
|
| 888 | SND 919 CL2 Y | - | - | - | - | [1] 6 6 💬
|
| 889 | SND 919 CL2Y | - | - | - | - | [1] 6 6 💬
|
| 890 | SNN0029 | - | - | - | - | [1] 2 2 💬
|
| 891 | SNN0029 infusion solution | - | - | - | - | [1] 2 2 💬
|
| 892 | SNN0031 | - | - | - | - | [1] 6 6 💬
|
| 893 | SNP-ACTH (1-39) Gel | - | - | - | - | [1] 222 222 💬
|
| 894 | SNSP113 | [1] SNSP113 SNSP113 | - | - | - | [1] 299 299 💬
|
| 895 | SNT-MC17 | - | - | - | - | [1] 113 113 💬
|
| 896 | SNUG01 | - | - | - | - | [1] 2 2 💬
|
| 897 | Sobetirome | [1] Sobetirome Sobetirome | [1] Sobetirome
Sobetirome
💬
| [1] THRB THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 💬
|
| 898 | Sobetirome (NV1205) | [1] Sobetirome Sobetirome | [1] Sobetirome
Sobetirome
💬
| [1] THRB THRB 💬
| [3] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 💬
|
| 899 | SOBI003 | - | - | - | - | [1] 19 19 💬
|
| 900 | SOC | - | - | - | - | [2] 47 47, 48 💬
|
| 901 | SOC (Standard of care) | - | - | - | - | [1] 46 46 💬
|
| 902 | SoC defined as maximal labelled or tolerated dose of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker (ACEi/ARB) & steady dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i) | - | - | - | - | [2] 66 66, 223 💬
|
| 903 | SoC Therapy | - | - | - | - | [1] 171 171 💬
|
| 904 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Bortezomib
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 905 | SOC: Phosphodiesterase type 5 (PDE-5) inhibitor | - | - | - | - | [1] 86 86 💬
|
| 906 | SOC: Soluble guanylate cyclase stimulator | - | - | - | - | [1] 86 86 💬
|
| 907 | Socks | - | - | - | - | [1] 6 6 💬
|
| 908 | SODIO ASCORBATO DC.IT | - | - | - | - | [1] 10 10 💬
|
| 909 | SODIO BICARBONATO | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [1] 299 299 💬
|
| 910 | SODIO BICARBONATO S.A.L.F. - 10 MEQ/10 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 5 FIALE 10 ML | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [1] 299 299 💬
|
| 911 | SODIO CLORURO | - | - | - | - | [1] 299 299 💬
|
| 912 | SODIO CLORURO S.A.L.F. - 2 MEQ/ ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 5 FIALE DA 10 ML | - | - | - | - | [1] 299 299 💬
|
| 913 | Sodio phenylbutyrate | - | - | - | - | [1] 2 2 💬
|
| 914 | SODIO SOLFATO ANIDRO | - | - | - | - | [1] 97 97 💬
|
| 915 | Sodio valproato | - | - | - | - | [1] 144 144 💬
|
| 916 | SODIUM | - | - | - | - | [1] 97 97 💬
|
| 917 | Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca | [1] Quinoline Quinoline | - | - | - | [1] 299 299 💬
|
| 918 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | [1] Pyrrolidine Pyrrolidine | - | - | - | [1] 97 97 💬
|
| 919 | Sodium 4-Phenylbutyrate | - | - | - | - | [1] 299 299 💬
|
| 920 | Sodium 4-Phenylbutyrate (4PBA) | - | - | - | - | [1] 299 299 💬
|
| 921 | Sodium acetate | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬
| - | - | [2] 81 81, 251 💬
|
| 922 | Sodium acetate (1-13C) | [2] Acetate Acetate, Sodium acetate | [1] Sodium acetate
Sodium acetate
💬
| - | - | [1] 251 251 💬
|
| 923 | SODIUM ACID PYROPHOSPHATE | - | - | - | - | [1] 166 166 💬
|
| 924 | SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE | - | - | - | - | [1] 166 166 💬
|
| 925 | Sodium alginate | [1] Alginic acid Alginic acid | [2] Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | [2] 53 53, 299 💬
|
| 926 | SODIUM ASCORBATE | [2] Ascorbic acid Ascorbic acid, Sodium ascorbate | [2] Ascorbic acid
Ascorbic acid
,
Sodium ascorbate
💬
| - | - | [1] 97 97 💬
|
| 927 | Sodium aurothiomalate | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] Gold sodium thiomalate
Gold sodium thiomalate
💬
| - | - | [1] 46 46 💬
|
| 928 | Sodium aurothiomalate (intramuscular gold) | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] Gold sodium thiomalate
Gold sodium thiomalate
💬
| - | - | [1] 46 46 💬
|
| 929 | Sodium bicarbonate | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [4] 67 67, 97, 226, 299 💬
|
| 930 | Sodium Bicarbonate 600 Mg Oral Tablet | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [1] 67 67 💬
|
| 931 | SODIUM BICARBONATE BP | [1] Sodium bicarbonate Sodium bicarbonate | [1] Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | [2] 97 97, 299 💬
|
| 932 | Sodium Butyrate | [1] Butyric Acid Butyric Acid | [1] Sodium butyrate
Sodium butyrate
💬
| - | - | [2] 46 46, 156 💬
|
| 933 | Sodium butyrate and zinc oxide | [2] Butyric Acid Butyric Acid, Zinc oxide | [2] Zinc oxide
Zinc oxide
,
Sodium butyrate
💬
| - | - | [1] 156 156 💬
|
| 934 | Sodium chlorid | - | - | - | - | [1] 13 13 💬
|
| 935 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 936 | Sodium chloride (7%) | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 937 | Sodium chloride (NaCl) | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 67 67 💬
|
| 938 | Sodium chloride 0,9% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 939 | Sodium Chloride 0.9% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [2] 14 14, 227 💬
|
| 940 | Sodium Chloride 0.9% Inj | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 298 298 💬
|
| 941 | Sodium chloride 6% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 942 | SODIUM CHLORIDE 7% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 943 | Sodium Chloride Injection | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 226 226 💬
|
| 944 | SODIUM CHLORIDE PH. EUR. | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 945 | Sodium Chloride solution | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 11 11, 13, 51, 228 💬
|
| 946 | SODIUM CHLORIDE SOLUTION 0.9% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 51 51, 60, 288, 299 💬
|
| 947 | Sodium Chloride Solvent | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 228 228 💬
|
| 948 | Sodium citrate | [1] Sodium citrate Sodium citrate | [1] Sodium citrate
Sodium citrate
💬
| - | - | [4] 67 67, 214, 215, 235 💬
|
| 949 | SODIUM CROMOGLICATE | - | - | - | - | [1] 85 85 💬
|
| 950 | Sodium Ethanoate (1- 13 C) | - | - | - | - | [1] 251 251 💬
|
| 951 | Sodium Ethanoate (1-13C) | - | - | - | - | [1] 251 251 💬
|
| 952 | Sodium fluoride | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬
| - | - | [1] 51 51 💬
|
| 953 | Sodium fluoride 18F | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬
| - | - | [1] 51 51 💬
|
| 954 | Sodium Fusidate | - | - | - | - | [1] 299 299 💬
|
| 955 | Sodium hyaluronate | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [6] 46 46, 53, 70, 97, 226, 279 💬
|
| 956 | Sodium hyaluronate(HA) and Sodium Carboxymethylcellulose(CMC)-based adhesion barrier | [2] Carboxymethylcellulose Carboxymethylcellulose, Hyaluronic acid | [4] Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Hyaluronate sodium
,
Carmellose
,
Hyaluronic acid
💬
| - | - | [1] 70 70 💬
|
| 957 | Sodium iodide | [2] Iodide Iodide, Sodium iodide | [3] Sodium iodide
Sodium iodide
,
Sodium iodide I 123
,
Sodium iodide I 125
💬
| - | - | [1] 34 34 💬
|
| 958 | Sodium Nitrate | [2] Nitrate Nitrate, Sodium nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [2] 58 58, 113 💬
|
| 959 | Sodium Nitrate - double dose | [2] Nitrate Nitrate, Sodium nitrate | [1] Nitric acid
Nitric acid
💬
| - | - | [1] 113 113 💬
|
| 960 | SODIUM NITRITE | [2] Nitrite Nitrite, Nitrous acid | [1] Sodium nitrite
Sodium nitrite
💬
| - | - | [2] 86 86, 299 💬
|
| 961 | Sodium Nitrite Inhalation Solution | [2] Nitrite Nitrite, Nitrous acid | [1] Sodium nitrite
Sodium nitrite
💬
| - | - | [1] 86 86 💬
|
| 962 | SODIUM NITROPRUSSIDE | [1] Nitroprusside Nitroprusside | [1] Sodium nitroprusside
Sodium nitroprusside
💬
| - | - | [1] 51 51 💬
|
| 963 | Sodium Oxybate | [1] Sodium oxybate Sodium oxybate | [1] Sodium oxybate
Sodium oxybate
💬
| - | - | [2] 6 6, 149 💬
|
| 964 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | [1] Sodium phenylbutyrate
Sodium phenylbutyrate
💬
| - | - | [5] 2 2, 3, 8, 18, 251 💬
|
| 965 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | [2] Polyethylene glycol Polyethylene glycol, Rifaximin | [4] Rifaximin
Rifaximin
,
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 6 6 💬
|
| 966 | Sodium Picosulfate, Magnesium Oxide and Citric Acid | [3] Citric acid Citric acid, Magnesium, Magnesium oxide | [3] Citric acid, anhydrous
Citric acid, anhydrous
,
Magnesium oxide
,
Citric acid monohydrate
💬
| - | - | [1] 291 291 💬
|
| 967 | Sodium Picosulfate/Magnesium Citrate Laxative | [2] Magnesium Magnesium, Magnesium citrate | [1] Magnesium citrate
Magnesium citrate
💬
| - | - | [1] 97 97 💬
|
| 968 | Sodium propionate | [1] Propanoic acid Propanoic acid | [3] Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | [1] 97 97 💬
|
| 969 | SODIUM PYRUVATE | [1] Pyruvic acid Pyruvic acid | - | - | - | [6] 2 2, 21, 67, 85, 299, 318 💬
|
| 970 | Sodium Pyruvate in 0.9% Sodium Chloride Solution | [2] Pyruvic acid Pyruvic acid, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 299 299 💬
|
| 971 | Sodium succinate | [1] Succinic acid Succinic acid | - | - | - | [11] 13 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
|
| 972 | Sodium sulfate | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [2] 28 28, 97 💬
|
| 973 | SODIUM SULFATE ANHYDROUS | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 974 | SODIUM SULPHATE ANHYDROUS | [1] Sodium sulfate Sodium sulfate | [2] Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | [1] 97 97 💬
|
| 975 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 976 | Sodium Thiosulfate | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 977 | Sodium Thiosulfate (STS) | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 978 | Sodium Thiosulfate 10% | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [2] 50 50, 51 💬
|
| 979 | Sodium Thiosulfate Injection | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [1] 51 51 💬
|
| 980 | SODIUM THIOSULFATE PENTAHYDRATE | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [2] 50 50, 51 💬
|
| 981 | Sodium Valproate | - | - | - | - | [3] 2 2, 102, 256 💬
|
| 982 | Sodium valproate 200 mg gastro-resistant tablets | - | - | - | - | [1] 233 233 💬
|
| 983 | Sodium Valproate 200Mg E/C Tablet | - | - | - | - | [1] 233 233 💬
|
| 984 | Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets | - | - | - | - | [1] 233 233 💬
|
| 985 | Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 💬
|
| 986 | Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 💬
|
| 987 | Sodium-glucose cotransporter 2 inhibitor | - | - | - | - | [1] 223 223 💬
|
| 988 | Sodiumchloride | - | - | - | - | [1] 67 67 💬
|
| 989 | Sofosbuvir | [1] Sofosbuvir Sofosbuvir | [1] Sofosbuvir
Sofosbuvir
💬
| - | - | [1] 19 19 💬
|
| 990 | Softacort | - | - | - | - | [1] 53 53 💬
|
| 991 | Sofusa DoseConnect | - | - | - | - | [1] 46 46 💬
|
| 992 | Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen | - | - | - | - | [1] 195 195 💬
|
| 993 | Sogroya 10 mg/1.5 mL solution for injection in pre-filled penPharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: SomapacitanOther descriptive name: SomapacitanConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 6.7-Product Name: somapacitan 5 mg/1.5 mL PDS290Pharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: SomapacitanOther descriptive name: SomapacitanConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 3.3-Product Name: Somapacitan 15 mg/1.5 mL PDS290Pharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: SomapacitanOther descriptive name: SomapacitanConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 10-Trade Name: Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled penPharmaceutical Form: Solution for injection in pre-filled penINN or Proposed INN: SomatropinOther descriptive name: SomatropinConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 6.7- | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬
|
| 994 | Sogroya 10 mg/1.5 mL soluzione per iniezione in penna pre-riempita | - | - | - | - | [1] 195 195 💬
|
| 995 | Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen | - | - | - | - | [1] 195 195 💬
|
| 996 | SOL-116 | - | - | - | - | [1] 46 46 💬
|
| 997 | Solaris | - | - | - | - | [2] 62 62, 109 💬
|
| 998 | SOLDESAM | - | - | - | - | [1] 28 28 💬
|
| 999 | SOLDESAM - 4 MG/ML SOLUZIONE INIETTABILE 3 FIALE 1 ML | - | - | - | - | [1] 28 28 💬
|
| 1000 | SOLFATO DI SODIO ANIDRO | - | - | - | - | [1] 97 97 💬
|
| 1001 | Solid food-based intervention | - | - | - | - | [1] 96 96 💬
|
| 1002 | Solifenacin | [1] Solifenacin Solifenacin | [2] Solifenacin succinate
Solifenacin succinate
,
Solifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [3] 6 6, 13, 53 💬
|
| 1003 | Solifenacin Succinate | [1] Solifenacin Solifenacin | [2] Solifenacin succinate
Solifenacin succinate
,
Solifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 💬
|
| 1004 | Solifenacin Succinate (VESIcare) | [1] Solifenacin Solifenacin | [2] Solifenacin succinate
Solifenacin succinate
,
Solifenacin
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 6 6 💬
|
| 1005 | SOLIGEN | - | - | - | - | [1] 6 6 💬
|
| 1006 | SOLIRIS | - | - | - | - | [6] 11 11, 13, 14, 62, 109, 223 💬
|
| 1007 | Soliris (eculizumab) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 1008 | Soliris (R) | - | - | - | - | [1] 61 61 💬
|
| 1009 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | - | - | - | - | [3] 13 13, 62, 109 💬
|
| 1010 | Soliris 300 | - | - | - | - | [1] 62 62 💬
|
| 1011 | SOLIRIS 300 mg concentrado para solución para perfusión | - | - | - | - | [1] 109 109 💬
|
| 1012 | Soliris 300 mg concentrate for solution for infusion | - | - | - | - | [1] 62 62 💬
|
| 1013 | Soliris 300 mg solution à diluer pour perfusion | - | - | - | - | [1] 109 109 💬
|
| 1014 | Soliris 300mg/30ml | - | - | - | - | [1] 62 62 💬
|
| 1015 | Soliris ™ (eculizumab) | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 1016 | Soliris/Ultomiris | - | - | - | - | [1] 62 62 💬
|
| 1017 | Soliris® | - | - | - | - | [1] 62 62 💬
|
| 1018 | Solondo | - | - | - | - | [1] 222 222 💬
|
| 1019 | Solriamfetol | [1] Solriamfetol Solriamfetol | [2] Solriamfetol
Solriamfetol
,
Solriamfetol hydrochloride
💬
| [2] SLC6A2 SLC6A2, SLC6A3 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 1020 | Solrikitug | [1] Solrikitug Solrikitug | [1] Solrikitug
Solrikitug
💬
| [1] CRLF2 CRLF2 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬
|
| 1021 | Solrikitug High Dose | [1] Solrikitug Solrikitug | [1] Solrikitug
Solrikitug
💬
| [1] CRLF2 CRLF2 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬
|
| 1022 | Solrikitug Low Dose | [1] Solrikitug Solrikitug | [1] Solrikitug
Solrikitug
💬
| [1] CRLF2 CRLF2 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬
|
| 1023 | Solrikitug Mid Dose | [1] Solrikitug Solrikitug | [1] Solrikitug
Solrikitug
💬
| [1] CRLF2 CRLF2 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬
|
| 1024 | SOLU MEDROL | - | - | - | - | [2] 56 56, 66 💬
|
| 1025 | SOLU MEDROL - 1000 MG/16 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 1000 MG+ 1 FLACONE SOLVENTE DA 16 ML | - | - | - | - | [1] 66 66 💬
|
| 1026 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 💬
|
| 1027 | SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML | - | - | - | - | [1] 56 56 💬
|
| 1028 | SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML | - | - | - | - | [1] 56 56 💬
|
| 1029 | Solu-Cortef | - | - | - | - | [3] 6 6, 81, 83 💬
|
| 1030 | Solu-Cortef (hydrocortisone) | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬
|
| 1031 | Solu-Cortef 100 MG Injection | - | - | - | - | [1] 83 83 💬
|
| 1032 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | - | - | - | - | [1] 6 6 💬
|
| 1033 | Solu-Medrol | - | - | - | - | [5] 13 13, 51, 53, 97, 211 💬
|
| 1034 | Solu-Medrol 1mg/kg | - | - | - | - | [1] 49 49 💬
|
| 1035 | Solu-Medrol 250 mg | - | - | - | - | [1] 49 49 💬
|
| 1036 | Solu-medrol inj. PSO LQF 40mg | - | - | - | - | [1] 50 50 💬
|
| 1037 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 💬
|
| 1038 | Solu-Medrone 125mg | - | - | - | - | [1] 46 46 💬
|
| 1039 | Solu-Medrone 2 Gram | - | - | - | - | [1] 46 46 💬
|
| 1040 | Solu-Medrone 2mg | - | - | - | - | [1] 46 46 💬
|
| 1041 | SOLU-MODERIN 1 g | - | - | - | - | [1] 13 13 💬
|
| 1042 | Soluble Fc receptor | - | - | - | - | [1] 49 49 💬
|
| 1043 | Soluble Fc-gamma receptor IIb | - | - | - | - | [1] 49 49 💬
|
| 1044 | Soluble fiber supplementation | - | - | - | - | [1] 299 299 💬
|
| 1045 | SOLUBLE PREDNISOLONE TABLETS | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 💬
|
| 1046 | Soluble protein hydrolysate (SPHi) | [1] Protein hydrolysate Protein hydrolysate | [1] Protein hydrolysate
Protein hydrolysate
💬
| - | - | [1] 97 97 💬
|
| 1047 | Soluble Ve cadherin | - | - | - | - | [1] 51 51 💬
|
| 1048 | Solucion de Cloruro de Sodio | - | - | - | - | [1] 228 228 💬
|
| 1049 | Solucion de cloruro de sodio Sodium Chloride Solution | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 228 228 💬
|
| 1050 | SoluMedrol | - | - | - | - | [3] 13 13, 46, 107 💬
|
| 1051 | Solumedrol IM 125mg/2ml | - | - | - | - | [1] 13 13 💬
|
| 1052 | Solution de chlorhydrate de dopamine anaérobie | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1053 | Soluzione di levodopa/carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1054 | Solvente Cloruro de Sodio Sodium Chloride Solvent | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 228 228 💬
|
| 1055 | Solvente de Cloruro de Sodio | - | - | - | - | [1] 228 228 💬
|
| 1056 | SOM022 | - | - | - | - | [1] 77 77 💬
|
| 1057 | SOM0226 | - | - | - | - | [1] 28 28 💬
|
| 1058 | SOM230 | - | - | - | - | [3] 74 74, 75, 77 💬
|
| 1059 | SOM230 300µg | - | - | - | - | [1] 75 75 💬
|
| 1060 | SOM230 600µg | - | - | - | - | [1] 75 75 💬
|
| 1061 | SOM230 900µg | - | - | - | - | [1] 75 75 💬
|
| 1062 | SOM230 LAR | - | - | - | - | [2] 75 75, 77 💬
|
| 1063 | SOM230 LAR 10 mg | - | - | - | - | [1] 75 75 💬
|
| 1064 | SOM230 LAR 30 mg | - | - | - | - | [1] 75 75 💬
|
| 1065 | SOM230 LAR, 20 mg | - | - | - | - | [2] 75 75, 77 💬
|
| 1066 | SOM230 s.c. | - | - | - | - | [1] 75 75 💬
|
| 1067 | SOM230, 300micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 1068 | SOM230, 600 micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 1069 | SOM230, 900 micrograms | - | - | - | - | [2] 75 75, 77 💬
|
| 1070 | SOM230B | - | - | - | - | [2] 75 75, 77 💬
|
| 1071 | SOM230C | - | - | - | - | [1] 77 77 💬
|
| 1072 | SOM3355 | - | - | - | - | [1] 8 8 💬
|
| 1073 | SOM3355 (bevantolol hydrochloride) | [1] Bevantolol Bevantolol | [1] Bevantolol hydrochloride
Bevantolol hydrochloride
💬
| [8] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [44] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 8 8 💬
|
| 1074 | SOM3355 100mg BID | - | - | - | - | [1] 8 8 💬
|
| 1075 | SOM3355 200 mg capsules | - | - | - | - | [1] 8 8 💬
|
| 1076 | SOM3355 200mg BID | - | - | - | - | [1] 8 8 💬
|
| 1077 | SOM3355 300 mg capsules | - | - | - | - | [1] 8 8 💬
|
| 1078 | Somalgen | - | - | - | - | [1] 299 299 💬
|
| 1079 | Somapacitan | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬
|
| 1080 | Somapacitan 15 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬
|
| 1081 | Somapacitan 5 mg/1.5 mL PDS290 | [1] Somapacitan Somapacitan | [1] Somapacitan
Somapacitan
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 195 195 💬
|
| 1082 | Somatic gene-therapy by X-CGD | - | - | - | - | [1] 65 65 💬
|
| 1083 | SomatoKine/IPLEX | - | - | - | - | [1] 113 113 💬
|
| 1084 | Somatorelin | [1] Somatorelin Somatorelin | [1] Somatorelin
Somatorelin
💬
| [1] GHRHR GHRHR 💬
| [3] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 1085 | Somatosensory evoked potential (SSEP) | - | - | - | - | [1] 13 13 💬
|
| 1086 | Somatostatin | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 77 💬
|
| 1087 | Somatostatin analog (lanreotide or octreotide) | [3] Lanreotide Lanreotide, Octreotide, Somatostatin | [7] Octreotide
Octreotide
,
Octreotide acetate
,
Lanreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Somatostatin
,
Octreotide hydrochloride
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1088 | Somatostatin Receptor Ligand (SRL) | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1089 | Somatotropin | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [3] 3 3, 65, 236 💬
|
| 1090 | Somatropin | - | - | - | - | [14] 3 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
|
| 1091 | Somatropin (DNA origin) | - | - | - | - | [1] 19 19 💬
|
| 1092 | Somatropin (rDNA origin) | - | - | - | - | [1] 78 78 💬
|
| 1093 | Somatropin - adult cohort | - | - | - | - | [1] 193 193 💬
|
| 1094 | Somatropin - GH naïve pediatric cohort | - | - | - | - | [1] 193 193 💬
|
| 1095 | Somatropin - GH treated cohort | - | - | - | - | [1] 193 193 💬
|
| 1096 | Somatropin [rDNA origin] for injection | - | - | - | - | [2] 46 46, 96 💬
|
| 1097 | SOMATROPIN FOR INJECTION | - | - | - | - | [1] 193 193 💬
|
| 1098 | Somatropin(rhGH) | - | - | - | - | [1] 96 96 💬
|
| 1099 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | [3] Clonidine Clonidine, Estradiol, Estradiol valerate | [5] Estradiol
Estradiol
,
Clonidine
,
Clonidine hydrochloride
,
Estradiol valerate
,
Estradiol hemihydrate
💬
| [5] ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2 💬
| [13] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 1100 | Somatropina | - | - | - | - | [1] 195 195 💬
|
| 1101 | SOMATULINA AUTOGEL | - | - | - | - | [1] 77 77 💬
|
| 1102 | Somatuline ATG | - | - | - | - | [1] 77 77 💬
|
| 1103 | Somatuline Autogel | - | - | - | - | [2] 67 67, 77 💬
|
| 1104 | Somatuline Autogel (lanreotide acetate) | [2] Acetate Acetate, Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1105 | Somatuline Autogel 120 | - | - | - | - | [1] 77 77 💬
|
| 1106 | SOMATULINE AUTOGEL 120 mg | - | - | - | - | [1] 77 77 💬
|
| 1107 | Somatuline Autogel 120mg | - | - | - | - | [1] 77 77 💬
|
| 1108 | Somatuline Autogel 60mg | - | - | - | - | [1] 77 77 💬
|
| 1109 | Somatuline Autogel 90 mg | - | - | - | - | [1] 298 298 💬
|
| 1110 | Somatuline Autogel 90mg | - | - | - | - | [1] 77 77 💬
|
| 1111 | Somatuline Autogel Injectable 120 | - | - | - | - | [1] 77 77 💬
|
| 1112 | Somatuline Autogel® (lanreotide) 60, 90, 120 mg. | [1] Lanreotide Lanreotide | [1] Lanreotide acetate
Lanreotide acetate
💬
| [2] SSTR2 SSTR2, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1113 | Somatuline Autogel® 60, 90 or 120 mg | - | - | - | - | [1] 77 77 💬
|
| 1114 | Somatuline Autosolution | - | - | - | - | [1] 67 67 💬
|
| 1115 | SOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie | - | - | - | - | [1] 77 77 💬
|
| 1116 | Somatuline LP 120mg | - | - | - | - | [1] 77 77 💬
|
| 1117 | SOMATULINE® AUTOGEL® 120 mg solution for injection | - | - | - | - | [1] 77 77 💬
|
| 1118 | SOMAVERT | - | - | - | - | [1] 77 77 💬
|
| 1119 | Somavert (Pegvisomant) | [1] Pegvisomant Pegvisomant | [1] Pegvisomant
Pegvisomant
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 77 77 💬
|
| 1120 | Somavert 10 mg | - | - | - | - | [1] 77 77 💬
|
| 1121 | SOMAVERT 15 mg | - | - | - | - | [1] 77 77 💬
|
| 1122 | SOMAVERT 20 mg | - | - | - | - | [1] 77 77 💬
|
| 1123 | Sonazoid | - | - | - | - | [1] 96 96 💬
|
| 1124 | Sonic toothbrush | - | - | - | - | [1] 51 51 💬
|
| 1125 | Sonic toothbrush (Philips Sonicare) and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 51 51 💬
|
| 1126 | Sonlicromanol | [1] Sonlicromanol Sonlicromanol | - | - | - | [1] 21 21 💬
|
| 1127 | SonoVue | - | - | - | - | [2] 96 96, 97 💬
|
| 1128 | Sonrotoclax | [1] Sonrotoclax Sonrotoclax | [1] Sonrotoclax
Sonrotoclax
💬
| [1] BCL2 BCL2 💬
| [40] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | [1] 28 28 💬
|
| 1129 | Soquelitinib | [1] Soquelitinib Soquelitinib | [1] Soquelitinib
Soquelitinib
💬
| [1] ITK ITK 💬
| [3] Chemokine signaling pathway Chemokine signaling pathway, Leukocyte transendothelial migration, T cell receptor signaling pathway 💬 | [1] 65 65 💬
|
| 1130 | SOR102 | - | - | - | - | [1] 97 97 💬
|
| 1131 | Sorafenib | [1] Sorafenib Sorafenib | [2] Sorafenib tosylate
Sorafenib tosylate
,
Sorafenib
💬
| [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [2] 34 34, 86 💬
|
| 1132 | Sorafenib (as tosylate) | [1] Sorafenib Sorafenib | [2] Sorafenib tosylate
Sorafenib tosylate
,
Sorafenib
💬
| [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 1133 | SORAPRAZAN | [1] Soraprazan Soraprazan | - | - | - | [1] 301 301 💬
|
| 1134 | Sorbitol | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬
| - | - | [2] 10 10, 97 💬
|
| 1135 | Sorbitol Sachet | [1] Sorbitol Sorbitol | [1] Sorbitol solution
Sorbitol solution
💬
| - | - | [1] 97 97 💬
|
| 1136 | SORBITOLO | - | - | - | - | [1] 10 10 💬
|
| 1137 | Sortis | - | - | - | - | [1] 93 93 💬
|
| 1138 | Sortis 10 mg | - | - | - | - | [1] 93 93 💬
|
| 1139 | Sortis 10 mg Filmtabletten | - | - | - | - | [1] 79 79 💬
|
| 1140 | Sortis 20 mg Filmtabletten | - | - | - | - | [1] 79 79 💬
|
| 1141 | Sortis 40 mg Filmtabletten | - | - | - | - | [1] 79 79 💬
|
| 1142 | Sotagliflozin | [1] Sotagliflozin Sotagliflozin | [1] Sotagliflozin
Sotagliflozin
💬
| [1] SLC5A1 SLC5A1 💬
| [3] Bile secretion Bile secretion, Carbohydrate digestion and absorption, Mineral absorption 💬 | [2] 58 58, 84 💬
|
| 1143 | SOTATERCEPT | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [2] 86 86, 284 💬
|
| 1144 | Sotatercept - 45 mg/vial | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬
|
| 1145 | Sotatercept - 60 mg/vial | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬
|
| 1146 | Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 55- | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬
|
| 1147 | Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 55- | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬
|
| 1148 | Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg | [1] Sotatercept Sotatercept | [1] Sotatercept
Sotatercept
💬
| [1] ACVR2A ACVR2A 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 💬
|
| 1149 | Sotatercept with prednisone boost | [2] Prednisone Prednisone, Sotatercept | [2] Prednisone
Prednisone
,
Sotatercept
💬
| [2] ACVR2A ACVR2A, NR3C1 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 284 284 💬
|
| 1150 | SotaterceptProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Lyophilisate for solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 86 86 💬
|
| 1151 | SotaterceptProduct Code: ACE-011/MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011/MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Lyophilisate for solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 86 86 💬
|
| 1152 | SOTICLESTAT | [1] Soticlestat Soticlestat | [1] Soticlestat
Soticlestat
💬
| [1] CYP46A1 CYP46A1 💬
| [1] Primary bile acid biosynthesis Primary bile acid biosynthesis 💬 | [2] 140 140, 144 💬
|
| 1153 | SoticlestatProduct Code: TAK-935Pharmaceutical Form: Film-coated tabletINN or Proposed INN: SOTICLESTATCAS Number: 1429505-03-2Current Sponsor code: TAK-935Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-Product Name: soticlestatProduct Code: TAK-935Pharmaceutical Form: Film-coated tabletINN or Proposed INN: SOTICLESTATCAS Number: 1429505-03-2Current Sponsor code: TAK-935Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 20- | - | - | - | - | [2] 140 140, 144 💬
|
| 1154 | Sotrastaurin | [1] Sotrastaurin Sotrastaurin | [2] Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
💬
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| [30] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1155 | Sotrastaurin (INN) acetate | [2] Acetate Acetate, Sotrastaurin | [2] Sotrastaurin
Sotrastaurin
,
Sotrastaurin acetate
💬
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬
| [30] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagosome formation, GnRH signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1156 | Sotuletinib | [1] BLZ-945 BLZ-945 | - | - | - | [1] 2 2 💬
|
| 1157 | Soy bread | - | - | - | - | [1] 298 298 💬
|
| 1158 | Soy protein | - | - | - | - | [2] 6 6, 96 💬
|
| 1159 | Soy protein diet | - | - | - | - | [1] 79 79 💬
|
| 1160 | Soy protein isolate | - | - | - | - | [1] 227 227 💬
|
| 1161 | Soy-tomato juice product | [1] Tomato Tomato | - | - | - | [1] 298 298 💬
|
| 1162 | Soya Bean oil | [1] Bean Bean | - | - | - | [1] 96 96 💬
|
| 1163 | SOYA LECITHIN | [1] Lecithin Lecithin | [1] Lecithin
Lecithin
💬
| - | - | [1] 340 340 💬
|
| 1164 | Soybean | [1] Soybean Soybean | - | - | - | [1] 97 97 💬
|
| 1165 | SOYBEAN PHOSPHATIDYLCHOLINE | [1] Soybean Soybean | - | - | - | [1] 97 97 💬
|
| 1166 | SP-101 | [1] SP-101 SP-101 | - | - | - | [1] 299 299 💬
|
| 1167 | SPARC0921 | - | - | - | - | [1] 13 13 💬
|
| 1168 | SPARSENTAN | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 66 66, 218, 222, 223 💬
|
| 1169 | Sparsentan compresse | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 1170 | Sparsentan tablets/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 1171 | Sparsentan tablets/over-encapsulated Spasenten tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 1172 | Sparsentan tablets/Overencapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 1173 | Sparsentan/Over-encapsulated Sparsentan tablet | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1174 | Sparsentan/Over-encapsulated Sparsentan tabletProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200- | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1175 | Sparsentan/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1176 | Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200- | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1177 | Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200- | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1178 | Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200- | [1] Sparsentan Sparsentan | [1] Sparsentan
Sparsentan
💬
| [2] AGTR1 AGTR1, EDNRA 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1179 | SparsentanProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200- | - | - | - | - | [1] 222 222 💬
|
| 1180 | SPC5001 | - | - | - | - | [1] 79 79 💬
|
| 1181 | SPD476 | - | - | - | - | [1] 97 97 💬
|
| 1182 | SPD476 (mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1183 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1184 | SPECT | - | - | - | - | [1] 6 6 💬
|
| 1185 | SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM | - | - | - | - | [1] 2 2 💬
|
| 1186 | SPECT imaging | - | - | - | - | [1] 6 6 💬
|
| 1187 | SPECT Imaging (180 Minutes post-injection) | - | - | - | - | [1] 46 46 💬
|
| 1188 | SPECT Imaging (60 Minutes post-injection) | - | - | - | - | [1] 46 46 💬
|
| 1189 | Speech and modified barium swallow study | [1] Barium Barium | - | - | - | [1] 19 19 💬
|
| 1190 | Sperti Del Sol Lamp | - | - | - | - | [1] 299 299 💬
|
| 1191 | Spesolilmab | - | - | - | - | [1] 96 96 💬
|
| 1192 | Spesolimab | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 37 37, 96, 97, 160, 269 💬
|
| 1193 | Spesolimab - solution for infusion | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 160 160 💬
|
| 1194 | Spesolimab - solution for injection | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 160 160 💬
|
| 1195 | Spesolimab IV infusion | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬
|
| 1196 | Spesolimab SC solution for injection | [1] Spesolimab Spesolimab | [1] Spesolimab
Spesolimab
💬
| [1] IL1RL2 IL1RL2 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 💬
|
| 1197 | Spevigo® | - | - | - | - | [1] 37 37 💬
|
| 1198 | SPG302 | [1] SPG302 SPG302 | - | - | - | [1] 2 2 💬
|
| 1199 | SPG601 | [1] SPG601 SPG601 | - | - | - | [1] 206 206 💬
|
| 1200 | SPH3127 | - | - | - | - | [1] 97 97 💬
|
| 1201 | SPH3127 Tablets with Dose A | - | - | - | - | [1] 97 97 💬
|
| 1202 | SPH3127 Tablets with Dose B | - | - | - | - | [1] 97 97 💬
|
| 1203 | SPH7854 | - | - | - | - | [1] 97 97 💬
|
| 1204 | Spheramine | [1] Spheramine Spheramine | - | - | - | [1] 6 6 💬
|
| 1205 | Spheramine (BAY86-5280) | [1] Spheramine Spheramine | - | - | - | [1] 6 6 💬
|
| 1206 | Sphingomyelin | - | - | - | - | [1] 79 79 💬
|
| 1207 | SPI-1005 Ebselen 200mg Capsule x1 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬
|
| 1208 | SPI-1005 Ebselen 200mg Capsule x2 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬
|
| 1209 | SPI-1005 Ebselen 200mg Capsule x3 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 💬
|
| 1210 | SPI-62 | - | - | - | - | [1] 75 75 💬
|
| 1211 | SPI-62 dose | - | - | - | - | [1] 75 75 💬
|
| 1212 | SPIF | - | - | - | - | [1] 95 95 💬
|
| 1213 | Spikevax | - | - | - | - | [1] 13 13 💬
|
| 1214 | Spinal anesthesia with tourniquet | - | - | - | - | [1] 46 46 💬
|
| 1215 | Spinal anesthesia without tourniquet | - | - | - | - | [1] 46 46 💬
|
| 1216 | Spinal tap | - | - | - | - | [1] 25 25 💬
|
| 1217 | Spinraza | - | - | - | - | [1] 3 3 💬
|
| 1218 | Spiriva Respimat 2.5 mcg | - | - | - | - | [1] 299 299 💬
|
| 1219 | Spiriva Respimat 2.5 microgram | - | - | - | - | [1] 299 299 💬
|
| 1220 | Spiriva Respimat 2.5 microgram, solution for inhalation | - | - | - | - | [1] 299 299 💬
|
| 1221 | Spirix | - | - | - | - | [1] 225 225 💬
|
| 1222 | Spironolactone | [1] Spironolactone Spironolactone | [1] Spironolactone
Spironolactone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [12] 46 46, 57, 58, 67, 86, 113, 210, 214, 218, 222, 223, 225 💬
|
| 1223 | Spironolactone (drug) | [1] Spironolactone Spironolactone | [1] Spironolactone
Spironolactone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 210 210 💬
|
| 1224 | Spironolactone and conivaptan | [2] Conivaptan Conivaptan, Spironolactone | [3] Spironolactone
Spironolactone
,
Conivaptan hydrochloride
,
Conivaptan
💬
| [3] AVPR1A AVPR1A, AVPR2, NR3C2 💬
| [7] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬
|
| 1225 | Spironolactone captopril carvedilol | [3] Captopril Captopril, Carvedilol, Spironolactone | [4] Captopril
Captopril
,
Carvedilol
,
Spironolactone
,
Carvedilol phosphate
💬
| [7] ACE ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬
| [21] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 1226 | Spironolactone Mylan 25 mg comprimé pelliculé sécable | [1] Spironolactone Spironolactone | [1] Spironolactone
Spironolactone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 46 46 💬
|
| 1227 | Spironolactone or Finerenone | [2] Finerenone Finerenone, Spironolactone | [2] Spironolactone
Spironolactone
,
Finerenone
💬
| [1] NR3C2 NR3C2 💬
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 218 218 💬
|
| 1228 | Spiropent | - | - | - | - | [2] 6 6, 13 💬
|
| 1229 | SPIROPENT*30CPR 0,02MG | - | - | - | - | [1] 57 57 💬
|
| 1230 | Spirulina platensis | [1] Spirulina platensis Spirulina platensis | - | - | - | [1] 299 299 💬
|
| 1231 | SPK-3006 | - | - | - | - | [1] 256 256 💬
|
| 1232 | SPL84 | - | - | - | - | [1] 299 299 💬
|
| 1233 | Spleen sample | - | - | - | - | [2] 61 61, 63 💬
|
| 1234 | SPM 926 | - | - | - | - | [1] 6 6 💬
|
| 1235 | SPM 962 | - | - | - | - | [1] 6 6 💬
|
| 1236 | SPM962 | - | - | - | - | [1] 6 6 💬
|
| 1237 | Sporanox | - | - | - | - | [2] 227 227, 299 💬
|
| 1238 | Sporanox 10 mg/ml Oral Solution | - | - | - | - | [1] 299 299 💬
|
| 1239 | SpotOn balance glasses | - | - | - | - | [1] 6 6 💬
|
| 1240 | SPR001 | - | - | - | - | [1] 81 81 💬
|
| 1241 | SPT3162 | - | - | - | - | [1] 145 145 💬
|
| 1242 | Sputum | - | - | - | - | [1] 299 299 💬
|
| 1243 | Sputum Collection | - | - | - | - | [2] 299 299, 340 💬
|
| 1244 | SPVN06 | - | - | - | - | [2] 90 90, 301 💬
|
| 1245 | SPX-101 | - | - | - | - | [1] 299 299 💬
|
| 1246 | SPY imaging | - | - | - | - | [1] 291 291 💬
|
| 1247 | SPY Portable Handheld Imaging (SPY-PHI) | - | - | - | - | [1] 235 235 💬
|
| 1248 | SPY001 | - | - | - | - | [1] 97 97 💬
|
| 1249 | SPY002 | - | - | - | - | [1] 97 97 💬
|
| 1250 | SPY002-072 | - | - | - | - | [1] 46 46 💬
|
| 1251 | SPY003 | - | - | - | - | [1] 97 97 💬
|
| 1252 | SQ Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 49 49, 223 💬
|
| 1253 | SQJZ herbal mixtures | - | - | - | - | [1] 6 6 💬
|
| 1254 | SR-878 | - | - | - | - | [1] 46 46 💬
|
| 1255 | SR-fampridine | - | - | - | - | [1] 13 13 💬
|
| 1256 | SR121463B | - | - | - | - | [1] 72 72 💬
|
| 1257 | SR140333B | - | - | - | - | [1] 97 97 💬
|
| 1258 | SR57667B | - | - | - | - | [1] 6 6 💬
|
| 1259 | SRD-001 | [1] SRD-001 SRD-001 | - | - | - | [2] 57 57, 113 💬
|
| 1260 | SRK-015 | - | - | - | - | [1] 3 3 💬
|
| 1261 | SRN-001 | - | - | - | - | [1] 85 85 💬
|
| 1262 | SRN001 | - | - | - | - | [1] 85 85 💬
|
| 1263 | SRP-1005 | - | - | - | - | [1] 8 8 💬
|
| 1264 | SRP-4045 | - | - | - | - | [1] 113 113 💬
|
| 1265 | SRP-4053 | - | - | - | - | [1] 113 113 💬
|
| 1266 | SRP-5051 | - | - | - | - | [1] 113 113 💬
|
| 1267 | SRP-6004 | [1] SRP-6004 SRP-6004 | - | - | - | [1] 113 113 💬
|
| 1268 | SRP-9001 | - | - | - | - | [1] 113 113 💬
|
| 1269 | SRP-9003 | - | - | - | - | [1] 113 113 💬
|
| 1270 | SRP-9004 | - | - | - | - | [1] 113 113 💬
|
| 1271 | SRP-9005 | [1] SRP-9005 SRP-9005 | - | - | - | [1] 113 113 💬
|
| 1272 | SRT2104 | - | - | - | - | [1] 97 97 💬
|
| 1273 | SRX246 | - | - | - | - | [2] 8 8, 206 💬
|
| 1274 | SS-1 | - | - | - | - | [1] 53 53 💬
|
| 1275 | SS-20 | - | - | - | - | [1] 8 8 💬
|
| 1276 | Ss-Adrenergic cocktail | - | - | - | - | [1] 299 299 💬
|
| 1277 | Ss-hydroxy-ß-methylbutyrate (HMB) | - | - | - | - | [1] 2 2 💬
|
| 1278 | Ss-hydroxybuturate esters | - | - | - | - | [1] 256 256 💬
|
| 1279 | Ss-interferon | - | - | - | - | [1] 13 13 💬
|
| 1280 | Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1281 | SSGJ-613 | - | - | - | - | [1] 107 107 💬
|
| 1282 | SSP-004184 100 mg | - | - | - | - | [1] 284 284 💬
|
| 1283 | SSP-004184 100 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1284 | SSP-004184 250 mg | - | - | - | - | [1] 284 284 💬
|
| 1285 | SSP-004184 250 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1286 | SSP-004184 375 mg | - | - | - | - | [1] 284 284 💬
|
| 1287 | SSP-004184 375 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1288 | SSP-004184 50 mg | - | - | - | - | [1] 284 284 💬
|
| 1289 | SSP-004184 50 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1290 | SSP-004184 500 mg | - | - | - | - | [1] 284 284 💬
|
| 1291 | SSP-004184 500 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1292 | SSP-004184AQ 100 mg | - | - | - | - | [1] 284 284 💬
|
| 1293 | SSP-004184AQ 100 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1294 | SSP-004184AQ 200 mg | - | - | - | - | [1] 284 284 💬
|
| 1295 | SSP-004184AQ 200 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1296 | SSP-004184AQ 250 mg | - | - | - | - | [1] 284 284 💬
|
| 1297 | SSP-004184AQ 250 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1298 | SSP-004184AQ 375 mg | - | - | - | - | [1] 284 284 💬
|
| 1299 | SSP-004184AQ 375 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1300 | SSP-004184AQ 50 mg | - | - | - | - | [1] 284 284 💬
|
| 1301 | SSP-004184AQ 50 mg Capsule | - | - | - | - | [1] 284 284 💬
|
| 1302 | SSR150106 | - | - | - | - | [1] 46 46 💬
|
| 1303 | SSR150106XB | - | - | - | - | [1] 46 46 💬
|
| 1304 | SST001 | - | - | - | - | [2] 6 6, 17 💬
|
| 1305 | SSZ | - | - | - | - | [1] 271 271 💬
|
| 1306 | ST 261 | - | - | - | - | [1] 97 97 💬
|
| 1307 | ST 36 | [1] ST-36 ST-36 | - | - | - | [2] 6 6, 49 💬
|
| 1308 | ST-0529 | - | - | - | - | [1] 97 97 💬
|
| 1309 | ST-920 | - | - | - | - | [1] 19 19 💬
|
| 1310 | ST10 | - | - | - | - | [2] 96 96, 97 💬
|
| 1311 | ST10-021 | - | - | - | - | [2] 96 96, 97 💬
|
| 1312 | ST200 | - | - | - | - | [1] 265 265 💬
|
| 1313 | ST261 | - | - | - | - | [1] 97 97 💬
|
| 1314 | ST36 | [1] ST-36 ST-36 | - | - | - | [2] 6 6, 46 💬
|
| 1315 | STA 5326 mesylate | - | - | - | - | [1] 46 46 💬
|
| 1316 | STA-5326 | - | - | - | - | [2] 65 65, 96 💬
|
| 1317 | STA-5326 mesylate | - | - | - | - | [1] 96 96 💬
|
| 1318 | STA-6838, STA-5326 m, S38 | - | - | - | - | [1] 96 96 💬
|
| 1319 | Stable isotope infusions | - | - | - | - | [1] 96 96 💬
|
| 1320 | Stable weekly dose of methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1321 | Stage II Surgical repair | - | - | - | - | [1] 211 211 💬
|
| 1322 | Stalevo | - | - | - | - | [1] 6 6 💬
|
| 1323 | Stalevo (levodopa/ carbidopa/ entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1324 | Stalevo (levodopa/carbidopa/entacapona) | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1325 | Stalevo (levodopa/carbidopa/entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1326 | Stalevo 100 | - | - | - | - | [1] 6 6 💬
|
| 1327 | Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten | - | - | - | - | [1] 6 6 💬
|
| 1328 | Stalevo 100 mg/25 mg / 200 mg | - | - | - | - | [1] 6 6 💬
|
| 1329 | Stalevo 100/25/200 mg | - | - | - | - | [1] 6 6 💬
|
| 1330 | Stalevo 150 | - | - | - | - | [1] 6 6 💬
|
| 1331 | Stalevo 150/37.5/200 mg | - | - | - | - | [1] 6 6 💬
|
| 1332 | STALEVO*100CPR 100/25/200MG | - | - | - | - | [1] 6 6 💬
|
| 1333 | STALEVO*100CPR 50/12,5/200MG | - | - | - | - | [1] 6 6 💬
|
| 1334 | Stalevo® | - | - | - | - | [1] 6 6 💬
|
| 1335 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 💬
|
| 1336 | Standard analgesia use [Fentanyl] | [1] Fentanyl Fentanyl | [3] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬
|
| 1337 | Standard analgesia use [Hydromorphone] | [1] Hydromorphone Hydromorphone | [2] Hydromorphone hydrochloride
Hydromorphone hydrochloride
,
Hydromorphone
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬
|
| 1338 | Standard analgesia use [Oxygen] | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 70 70 💬
|
| 1339 | Standard analgesia use [Volatile Anesthesia] | - | - | - | - | [1] 70 70 💬
|
| 1340 | Standard Care | - | - | - | - | [2] 81 81, 299 💬
|
| 1341 | Standard care + rotigotine at 4 mg/24h for 24 months. | [1] Rotigotine Rotigotine | [1] Rotigotine
Rotigotine
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 67 67 💬
|
| 1342 | Standard care for 24 months. | - | - | - | - | [1] 67 67 💬
|
| 1343 | Standard care Hyaluronic acid eye drops | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [1] 53 53 💬
|
| 1344 | Standard clear liquid diet | - | - | - | - | [1] 96 96 💬
|
| 1345 | Standard continuous antiretroviral therapy | - | - | - | - | [1] 265 265 💬
|
| 1346 | Standard DMARDs (Disease Modifying Anti Rheumatic Drugs) | - | - | - | - | [1] 46 46 💬
|
| 1347 | Standard dose Influenza vaccine (SDIV) | - | - | - | - | [1] 97 97 💬
|
| 1348 | Standard dose of HCQ | - | - | - | - | [1] 49 49 💬
|
| 1349 | Standard dose of rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 💬
|
| 1350 | Standard Dose YPT-01 | - | - | - | - | [1] 299 299 💬
|
| 1351 | Standard Formula | - | - | - | - | [1] 299 299 💬
|
| 1352 | Standard formula (Enfamil) | - | - | - | - | [1] 299 299 💬
|
| 1353 | Standard gadolinium contrast | [1] Gadolinium Gadolinium | - | - | - | [1] 13 13 💬
|
| 1354 | Standard glucocorticoid therapy | - | - | - | - | [1] 81 81 💬
|
| 1355 | Standard hepatitis B vaccine | - | - | - | - | [1] 97 97 💬
|
| 1356 | Standard infliximab intravenous therapy | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1357 | Standard interval dosing | - | - | - | - | [1] 13 13 💬
|
| 1358 | Standard intravenous omeprazole therapy (40 mg IV once daily at 6:00 AM). | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 97 97 💬
|
| 1359 | Standard IST combined with Romiplostim N01 | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 60 60 💬
|
| 1360 | Standard LD/CD | - | - | - | - | [1] 6 6 💬
|
| 1361 | Standard lipid lowering therapy | - | - | - | - | [1] 79 79 💬
|
| 1362 | Standard Lymphodepletion regimen | - | - | - | - | [3] 11 11, 13, 51 💬
|
| 1363 | Standard Medical Therapy | - | - | - | - | [1] 57 57 💬
|
| 1364 | Standard medical treatment | - | - | - | - | [1] 50 50 💬
|
| 1365 | Standard monitoring | - | - | - | - | [1] 22 22 💬
|
| 1366 | Standard MS DMT | - | - | - | - | [1] 13 13 💬
|
| 1367 | Standard MS DMTs | - | - | - | - | [1] 13 13 💬
|
| 1368 | Standard Nutritional Supplement + PERT | - | - | - | - | [1] 299 299 💬
|
| 1369 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 1370 | Standard of Care (SOC) | - | - | - | - | [5] 43 43, 44, 49, 85, 171 💬
|
| 1371 | Standard of Care (SOC): Endothelin receptor antagonist | - | - | - | - | [1] 86 86 💬
|
| 1372 | Standard of Care - Double Oral | - | - | - | - | [1] 86 86 💬
|
| 1373 | Standard of Care Chemotherapy | - | - | - | - | [1] 28 28 💬
|
| 1374 | Standard of Care IST | - | - | - | - | [1] 222 222 💬
|
| 1375 | Standard of care IV antibiotic(s) | - | - | - | - | [1] 299 299 💬
|
| 1376 | Standard of Care Medications | - | - | - | - | [1] 171 171 💬
|
| 1377 | Standard of care therapy | - | - | - | - | [1] 28 28 💬
|
| 1378 | Standard of Care Treatment | - | - | - | - | [6] 11 11, 49, 53, 96, 245, 246 💬
|
| 1379 | Standard of Care: UDCA | - | - | - | - | [1] 93 93 💬
|
| 1380 | Standard Oral Prednisolone Regimen with Tapering | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 💬
|
| 1381 | Standard oxygen therapy/RA | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 299 299 💬
|
| 1382 | Standard Plasma | - | - | - | - | [1] 64 64 💬
|
| 1383 | Standard prednisolone taper | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 1384 | Standard prednisolone treatment | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1385 | Standard Regimen | - | - | - | - | [1] 107 107 💬
|
| 1386 | Standard step-up care | - | - | - | - | [1] 96 96 💬
|
| 1387 | Standard Steroid Treatment | - | - | - | - | [1] 85 85 💬
|
| 1388 | Standard therapy | - | - | - | - | [5] 49 49, 51, 58, 97, 195 💬
|
| 1389 | Standard Therapy (ACEI or ARB). | - | - | - | - | [1] 222 222 💬
|
| 1390 | Standard therapy (Excluding Immunosuppressants) | - | - | - | - | [1] 49 49 💬
|
| 1391 | Standard therapy (Including Immunosuppressants) | - | - | - | - | [1] 49 49 💬
|
| 1392 | Standard therapy (without eltrombopag): HD-DXM | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 1393 | Standard therapy of septic shock | - | - | - | - | [1] 60 60 💬
|
| 1394 | Standard treatment | - | - | - | - | [2] 6 6, 71 💬
|
| 1395 | Standard Treatment group | - | - | - | - | [1] 51 51 💬
|
| 1396 | Standard treatment with a conventional drug | - | - | - | - | [1] 13 13 💬
|
| 1397 | Standard Varenicline Dosing (1 mg BID) | [1] Varenicline Varenicline | [2] Varenicline tartrate
Varenicline tartrate
,
Varenicline
💬
| [2] CHRNA4 CHRNA4, CHRNB2 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | [1] 298 298 💬
|
| 1398 | Standard Vitamin D3 Supplementation | - | - | - | - | [1] 60 60 💬
|
| 1399 | Standard-Dose Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1400 | Standard-Dose infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1401 | Standard-dose vitamin D (400IU per day) | [1] Vitamin D Vitamin D | - | - | - | [1] 274 274 💬
|
| 1402 | Standard-of-care | - | - | - | - | [1] 13 13 💬
|
| 1403 | Standard-of-care treatment | - | - | - | - | [1] 49 49 💬
|
| 1404 | Standardized anthocyanin-rich extract | - | - | - | - | [1] 97 97 💬
|
| 1405 | Standardized antihypertensive therapy | - | - | - | - | [1] 75 75 💬
|
| 1406 | Standardized cannabis extract | - | - | - | - | [1] 13 13 💬
|
| 1407 | Standardized FMT | - | - | - | - | [1] 97 97 💬
|
| 1408 | Standardized FODMAP | - | - | - | - | [1] 97 97 💬
|
| 1409 | Standardized Ginkgo Biloba Extract (EGb 761 (r) | [1] Ginkgo biloba Ginkgo biloba | [1] Ginkgo
Ginkgo
💬
| - | - | [1] 18 18 💬
|
| 1410 | Standardized meal | - | - | - | - | [2] 93 93, 94 💬
|
| 1411 | Standardized turmeric root extract | [1] Turmeric Turmeric | - | - | - | [1] 299 299 💬
|
| 1412 | Standart of care | - | - | - | - | [1] 96 96 💬
|
| 1413 | Stanozolol | [1] Stanozolol Stanozolol | [1] Stanozolol
Stanozolol
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 60 60 💬
|
| 1414 | Stapokibart | [1] Stapokibart Stapokibart | - | - | - | [1] 162 162 💬
|
| 1415 | Stapokibart injection | [1] Stapokibart Stapokibart | - | - | - | [1] 162 162 💬
|
| 1416 | STAR-0215 | - | - | - | - | [1] 65 65 💬
|
| 1417 | STAR-0215 (IV) | - | - | - | - | [1] 65 65 💬
|
| 1418 | STAR-0215 (SC) | - | - | - | - | [1] 65 65 💬
|
| 1419 | StarGen | - | - | - | - | [1] 301 301 💬
|
| 1420 | Start adalimumab in monotherapy | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 1421 | Static, dynamic and functional balance exercises | - | - | - | - | [1] 6 6 💬
|
| 1422 | Static, dynamic and functional balance exercises with dual task | - | - | - | - | [1] 6 6 💬
|
| 1423 | Statin | - | - | - | - | [1] 13 13 💬
|
| 1424 | Statins | - | - | - | - | [2] 46 46, 79 💬
|
| 1425 | Statins and Ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 💬
|
| 1426 | Statins and/or Ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 79 79 💬
|
| 1427 | Status Post Lung Transplant | - | - | - | - | [1] 228 228 💬
|
| 1428 | Stavudine | [1] Stavudine Stavudine | [1] Stavudine
Stavudine
💬
| - | - | [1] 265 265 💬
|
| 1429 | Stelara | - | - | - | - | [6] 49 49, 56, 96, 97, 269, 271 💬
|
| 1430 | Stelara (ustekinumab) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 65 65 💬
|
| 1431 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1432 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | - | - | - | - | [2] 96 96, 97 💬
|
| 1433 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | - | - | - | - | [2] 96 96, 97 💬
|
| 1434 | STELARA 130 mg concentrate for solution for infusion | - | - | - | - | [1] 96 96 💬
|
| 1435 | Stelara 130mg / 26mL concentrate for solution for infusion | - | - | - | - | [1] 96 96 💬
|
| 1436 | Stelara 45 mg solution for injection | - | - | - | - | [1] 96 96 💬
|
| 1437 | STELARA 90 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 96 96 💬
|
| 1438 | Stelara 90 mg solution for injection n pre-filled syringue | - | - | - | - | [1] 96 96 💬
|
| 1439 | Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS) | - | - | - | - | [1] 96 96 💬
|
| 1440 | Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra | - | - | - | - | [1] 96 96 💬
|
| 1441 | STELARA® | - | - | - | - | [3] 49 49, 96, 97 💬
|
| 1442 | STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injectionINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200-Trade Name: STELARA®Product Name: UstekinumabProduct Code: CNTO1275Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: UstekinumabCAS Number: 815610-63-0Current Sponsor code: CNTO1275Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: up toConcentration number: 200- | - | - | - | - | [2] 96 96, 97 💬
|
| 1443 | STELARA¿ | - | - | - | - | [1] 96 96 💬
|
| 1444 | Stellate ganglion block | - | - | - | - | [1] 6 6 💬
|
| 1445 | Stem Cell | - | - | - | - | [3] 2 2, 113, 296 💬
|
| 1446 | Stem cell (HPC) implantation | - | - | - | - | [1] 2 2 💬
|
| 1447 | Stem Cell Collection | - | - | - | - | [1] 28 28 💬
|
| 1448 | Stem cell implantation | - | - | - | - | [1] 90 90 💬
|
| 1449 | Stem Cell Infusion | - | - | - | - | [4] 28 28, 60, 65, 284 💬
|
| 1450 | Stem cell injection | - | - | - | - | [1] 57 57 💬
|
| 1451 | Stem Cell Isolation | - | - | - | - | [1] 28 28 💬
|
| 1452 | Stem Cell or Umbilical Cord Blood Transplantation | - | - | - | - | [1] 326 326 💬
|
| 1453 | Stem cell therapy | - | - | - | - | [2] 5 5, 57 💬
|
| 1454 | Stem Cell Therapy - Experimental | - | - | - | - | [1] 6 6 💬
|
| 1455 | Stem Cell Transplant | - | - | - | - | [6] 19 19, 20, 60, 65, 164, 284 💬
|
| 1456 | Stem Cell Transplantation | - | - | - | - | [14] 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 1457 | Stem Cells | - | - | - | - | [4] 2 2, 4, 96, 113 💬
|
| 1458 | STEM-PD | - | - | - | - | [1] 6 6 💬
|
| 1459 | STEM-PD Product | - | - | - | - | [1] 6 6 💬
|
| 1460 | Stem/progenitor cells transplantation | - | - | - | - | [2] 90 90, 301 💬
|
| 1461 | Stemchymal | - | - | - | - | [1] 18 18 💬
|
| 1462 | Stemchymal® | - | - | - | - | [1] 18 18 💬
|
| 1463 | Stempeucel(R) | - | - | - | - | [1] 47 47 💬
|
| 1464 | StemRegen product | - | - | - | - | [1] 6 6 💬
|
| 1465 | Step-up | - | - | - | - | [1] 96 96 💬
|
| 1466 | Stereotactic surgical device | - | - | - | - | [1] 2 2 💬
|
| 1467 | Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [4] 62 62, 79, 234, 254 💬
|
| 1468 | Sterile Normal Saline for Intravenous Use | - | - | - | - | [2] 85 85, 229 💬
|
| 1469 | STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V) | - | - | - | - | [1] 299 299 💬
|
| 1470 | Sterile saline | - | - | - | - | [1] 227 227 💬
|
| 1471 | Sterile saline for injection | - | - | - | - | [1] 97 97 💬
|
| 1472 | Sterile saline solution | - | - | - | - | [1] 51 51 💬
|
| 1473 | Sterile Water for Injection | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 215 215 💬
|
| 1474 | Steroid | - | - | - | - | [4] 95 95, 107, 222, 288 💬
|
| 1475 | Steroid & Cyclosporin | - | - | - | - | [1] 222 222 💬
|
| 1476 | Steroid and eltrombopage | - | - | - | - | [1] 63 63 💬
|
| 1477 | Steroid and Proton Pump Inhibitor Therapy | - | - | - | - | [1] 98 98 💬
|
| 1478 | Steroid Drug | - | - | - | - | [3] 11 11, 46, 49 💬
|
| 1479 | Steroid injections | - | - | - | - | [1] 70 70 💬
|
| 1480 | Steroid pulse therapy group | - | - | - | - | [1] 85 85 💬
|
| 1481 | Steroid Taper | - | - | - | - | [1] 49 49 💬
|
| 1482 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 1483 | Steroids plus azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 66 66 💬
|
| 1484 | STG-001 | [1] STG-001 STG-001 | - | - | - | [1] 301 301 💬
|
| 1485 | STI-6129 | - | - | - | - | [1] 28 28 💬
|
| 1486 | STI571 | - | - | - | - | [2] 51 51, 86 💬
|
| 1487 | Stilnoct | - | - | - | - | [1] 6 6 💬
|
| 1488 | STIM ON plus | - | - | - | - | [1] 6 6 💬
|
| 1489 | Stimulator OFF | - | - | - | - | [1] 6 6 💬
|
| 1490 | Stimulator ON | - | - | - | - | [1] 6 6 💬
|
| 1491 | Stiripentol | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬
| - | - | [2] 140 140, 234 💬
|
| 1492 | Stiripentol (Diacomit) | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬
| - | - | [1] 234 234 💬
|
| 1493 | Stiripentol capsule (Diacomit®) | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬
| - | - | [1] 140 140 💬
|
| 1494 | Stiripentol Oral Capsule | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬
| - | - | [1] 234 234 💬
|
| 1495 | Stiripentol oral suspension (Diacomit®) | [1] Stiripentol Stiripentol | [1] Stiripentol
Stiripentol
💬
| - | - | [1] 140 140 💬
|
| 1496 | Stiripentolo | - | - | - | - | [1] 140 140 💬
|
| 1497 | STK-001 - Multiple Ascending Doses | - | - | - | - | [1] 140 140 💬
|
| 1498 | STK-001 - Single Ascending Doses | - | - | - | - | [1] 140 140 💬
|
| 1499 | STK-009 | - | - | - | - | [2] 49 49, 51 💬
|
| 1500 | STNM01 | - | - | - | - | [1] 97 97 💬
|
| 1501 | STNM01 1.84 mg | - | - | - | - | [1] 97 97 💬
|
| 1502 | Stood sample | - | - | - | - | [1] 49 49 💬
|
| 1503 | Stool analysis | - | - | - | - | [1] 46 46 💬
|
| 1504 | Stool sample | - | - | - | - | [1] 49 49 💬
|
| 1505 | Stool samples | - | - | - | - | [2] 97 97, 160 💬
|
| 1506 | Stool sampling | - | - | - | - | [2] 97 97, 98 💬
|
| 1507 | Stool simple | - | - | - | - | [1] 96 96 💬
|
| 1508 | Stools | - | - | - | - | [1] 46 46 💬
|
| 1509 | STOP arm | - | - | - | - | [1] 84 84 💬
|
| 1510 | STR04 | - | - | - | - | [1] 2 2 💬
|
| 1511 | Strattera | - | - | - | - | [2] 6 6, 230 💬
|
| 1512 | Strensiq | - | - | - | - | [1] 172 172 💬
|
| 1513 | Strimvelis | [1] Strimvelis Strimvelis | - | - | - | [1] 65 65 💬
|
| 1514 | Stromal Vascular fraction | - | - | - | - | [1] 51 51 💬
|
| 1515 | Stromal vascular fraction (SVF) | - | - | - | - | [2] 71 71, 96 💬
|
| 1516 | STS | - | - | - | - | [2] 50 50, 51 💬
|
| 1517 | STSA-1301 subcutaneous injection | - | - | - | - | [1] 63 63 💬
|
| 1518 | Study Drug | - | - | - | - | [3] 6 6, 13, 74 💬
|
| 1519 | Study Drug- ALXN1007 | - | - | - | - | [1] 48 48 💬
|
| 1520 | Study for the correlation of SNPs with efficacy and toxicity of Leflunomide in RA patients | [1] Leflunomide Leflunomide | [1] Leflunomide
Leflunomide
💬
| [1] DHODH DHODH 💬
| [1] Pyrimidine metabolism Pyrimidine metabolism 💬 | [1] 46 46 💬
|
| 1521 | Study medication, azithromycin | [1] Azithromycin Azithromycin | [3] Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | [1] 299 299 💬
|
| 1522 | Study of the gene expression profile | - | - | - | - | [1] 51 51 💬
|
| 1523 | Study treatment PPI | - | - | - | - | [1] 166 166 💬
|
| 1524 | STW5-II | - | - | - | - | [1] 97 97 💬
|
| 1525 | STW5-II (Iberogast N, BAY98-7410) | - | - | - | - | [1] 97 97 💬
|
| 1526 | STX107 | - | - | - | - | [1] 206 206 💬
|
| 1527 | STX209 | - | - | - | - | [1] 206 206 💬
|
| 1528 | Sub-Study: Nintedanib | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬
|
| 1529 | Sub-Study: Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 1530 | SUB03255MIG | - | - | - | - | [1] 85 85 💬
|
| 1531 | SUB0750MIG | - | - | - | - | [1] 13 13 💬
|
| 1532 | SUB08357MIG | - | - | - | - | [1] 57 57 💬
|
| 1533 | SUB09246MIG | - | - | - | - | [1] 18 18 💬
|
| 1534 | SUB10020MIG | - | - | - | - | [1] 85 85 💬
|
| 1535 | SUB126308 | - | - | - | - | [1] 2 2 💬
|
| 1536 | SUB16402MIG | - | - | - | - | [1] 227 227 💬
|
| 1537 | SUB175614 | - | - | - | - | [1] 13 13 💬
|
| 1538 | SUB180983 | - | - | - | - | [1] 107 107 💬
|
| 1539 | SUB185183 | - | - | - | - | [1] 299 299 💬
|
| 1540 | SUB195712 | - | - | - | - | [1] 19 19 💬
|
| 1541 | SUB20016 | - | - | - | - | [2] 96 96, 97 💬
|
| 1542 | SUB21605 | - | - | - | - | [1] 225 225 💬
|
| 1543 | SUB21634 | - | - | - | - | [1] 235 235 💬
|
| 1544 | SUB22282 | - | - | - | - | [1] 13 13 💬
|
| 1545 | Subcutaneous (SC) Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1546 | Subcutaneous Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1547 | Subcutaneous and intravenous prostacyclin | - | - | - | - | [1] 86 86 💬
|
| 1548 | Subcutaneous apomorphine | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1549 | Subcutaneous Beloranib in Suspension | [1] Beloranib Beloranib | - | - | - | [1] 193 193 💬
|
| 1550 | Subcutaneous hydrocortisone | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1551 | Subcutaneous hydrocortisone 10mg | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 1552 | Subcutaneous immune globulin G | - | - | - | - | [1] 14 14 💬
|
| 1553 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 💬
|
| 1554 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 1555 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬
|
| 1556 | Subcutaneous infliximab CT-P13 Remsima®SC | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 97 💬
|
| 1557 | Subcutaneous polyvidone collagen | - | - | - | - | [1] 46 46 💬
|
| 1558 | Subcutaneous tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 1559 | Subcutaneous tocilizumab 162mg/biweekly | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 1560 | Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1561 | Subcutaneous Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 56 56 💬
|
| 1562 | Subcutaneous(SC) Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1] 46 46 💬
|
| 1563 | Subcutanious administration | - | - | - | - | [1] 46 46 💬
|
| 1564 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 💬
|
| 1565 | Subgam | - | - | - | - | [1] 65 65 💬
|
| 1566 | Subjects will undergo the 123-I IBVM imaging visit | - | - | - | - | [1] 6 6 💬
|
| 1567 | Sublimated mare milk | - | - | - | - | [1] 93 93 💬
|
| 1568 | Sublingual nitroglycerine | - | - | - | - | [1] 46 46 💬
|
| 1569 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [2] Tizanidine hydrochloride
Tizanidine hydrochloride
,
Tizanidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
| 1570 | Submucosal Bevacizumab | [1] Bevacizumab Bevacizumab | [1] Bevacizumab
Bevacizumab
💬
| [1] VEGFA VEGFA 💬
| [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 227 227 💬
|
| 1571 | Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus | - | - | - | - | [1] 90 90 💬
|
| 1572 | Subretinal injection of rAAV.hPDE6A | - | - | - | - | [1] 90 90 💬
|
| 1573 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | [1] 90 90 💬
|
| 1574 | Subtenon Injection of Autologous Platelet-Rich Plasma | - | - | - | - | [1] 90 90 💬
|
| 1575 | Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes | - | - | - | - | [1] 90 90 💬
|
| 1576 | Subtenon injection of Wharton jelly derived mesenchymal stem cells | - | - | - | - | [1] 90 90 💬
|
| 1577 | Sucralfate | [1] Sucralfate Sucralfate | [1] Sucralfate
Sucralfate
💬
| - | - | [1] 98 98 💬
|
| 1578 | Sucrose | [1] Sucrose Sucrose | [1] Sucrose
Sucrose
💬
| - | - | [4] 62 62, 96, 97, 127 💬
|
| 1579 | Sucrosomial Iron | [1] Iron Iron | [1] Ferrous fumarate
Ferrous fumarate
💬
| - | - | [1] 97 97 💬
|
| 1580 | Sudoscan and clinical assessment | - | - | - | - | [1] 6 6 💬
|
| 1581 | Sufentanil | [1] Sufentanil Sufentanil | [2] Sufentanil citrate
Sufentanil citrate
,
Sufentanil
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 11 11, 22, 46, 70, 280 💬
|
| 1582 | Sugammadex | [1] Sugammadex Sugammadex | [1] Sugammadex sodium
Sugammadex sodium
💬
| - | - | [1] 11 11 💬
|
| 1583 | Sugar Extract | - | - | - | - | [2] 96 96, 97 💬
|
| 1584 | Sugar pill | - | - | - | - | [9] 5 5, 6, 49, 67, 70, 86, 120, 206, 210 💬
|
| 1585 | SUL-238 (1500 mg t.i.d.) film-coated tablets | - | - | - | - | [1] 6 6 💬
|
| 1586 | SUL-238 (500 mg t.i.d.) film-coated tablets | - | - | - | - | [1] 6 6 💬
|
| 1587 | Sulbactam | [1] Sulbactam Sulbactam | [3] Sulbactam sodium
Sulbactam sodium
,
Sulbactam benzathine
,
Sulbactam
💬
| - | - | [1] 299 299 💬
|
| 1588 | Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) | [2] Durlobactam Durlobactam, Sulbactam | [5] Sulbactam sodium
Sulbactam sodium
,
Sulbactam benzathine
,
Sulbactam
,
Durlobactam
,
Durlobactam sodium
💬
| - | - | [1] 299 299 💬
|
| 1589 | Sulfadoxine | [1] Sulfadoxine Sulfadoxine | [1] Sulfadoxine
Sulfadoxine
💬
| - | - | [1] 65 65 💬
|
| 1590 | SULFAMETH | - | - | - | - | [1] 60 60 💬
|
| 1591 | Sulfamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | [8] 35 35, 44, 49, 61, 85, 223, 296, 299 💬
|
| 1592 | Sulfasalazin | - | - | - | - | [1] 54 54 💬
|
| 1593 | SULFASALAZINE | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [7] 46 46, 49, 86, 94, 107, 270, 271 💬
|
| 1594 | Sulfasalazine + Hydroxychloroquine | [2] Hydroxychloroquine Hydroxychloroquine, Sulfasalazine | [3] Sulfasalazine
Sulfasalazine
,
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [1] 46 46 💬
|
| 1595 | Sulfasalazine Tablets | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [1] 49 49 💬
|
| 1596 | Sulfasalazine, SSZ | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [1] 271 271 💬
|
| 1597 | SULFATE | - | - | - | - | [1] 97 97 💬
|
| 1598 | Sulfate d'hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [2] Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | [2] 48 48, 53 💬
|
| 1599 | Sulfate, Magnesium | [1] Magnesium Magnesium | - | - | - | [1] 64 64 💬
|
| 1600 | Sulfato de amikacina | [1] Amikacin Amikacin | [2] Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | [1] 299 299 💬
|
| 1601 | Sulforaphane | [1] Sulforaphane Sulforaphane | - | - | - | [2] 6 6, 205 💬
|
| 1602 | Sulfotanshinone Sodium Injection | - | - | - | - | [1] 224 224 💬
|
| 1603 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [3] 96 96, 97, 215 💬
|
| 1604 | Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [1] 215 215 💬
|
| 1605 | Sulindac | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬
|
| 1606 | Sulindac (HLX-0201), dose strength 1 | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬
|
| 1607 | Sulindac (HLX-0201), dose strength 2 | [1] Sulindac Sulindac | [1] Sulindac
Sulindac
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 💬
|
| 1608 | Sulphamethoxazole | - | - | - | - | [1] 85 85 💬
|
| 1609 | Sulphasalazine | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [2] 46 46, 271 💬
|
| 1610 | Sulphasalazine (SSZ) | - | - | - | - | [1] 271 271 💬
|
| 1611 | Sulphasalazine 500 mg En-Tabs | [1] Sulfasalazine Sulfasalazine | [1] Sulfasalazine
Sulfasalazine
💬
| - | - | [1] 271 271 💬
|
| 1612 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | [1] 97 97 💬
|
| 1613 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | [2] 96 96, 97 💬
|
| 1614 | Sumanirole | [1] Sumanirole Sumanirole | - | - | - | [1] 6 6 💬
|
| 1615 | Sunflower Oil | [1] Sunflower oil Sunflower oil | [1] Sunflower oil
Sunflower oil
💬
| - | - | [4] 13 13, 46, 79, 299 💬
|
| 1616 | Sunitinib | [1] Sunitinib Sunitinib | [2] Sunitinib malate
Sunitinib malate
,
Sunitinib
💬
| [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬
| [38] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 28 28, 34 💬
|
| 1617 | Sunitinib malate | [1] Sunitinib Sunitinib | [2] Sunitinib malate
Sunitinib malate
,
Sunitinib
💬
| [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬
| [38] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 28 28 💬
|
| 1618 | SUNPG1622 I dose | - | - | - | - | [1] 271 271 💬
|
| 1619 | Sunphenon | - | - | - | - | [2] 13 13, 113 💬
|
| 1620 | Sunphenon EGCG | - | - | - | - | [3] 13 13, 17, 113 💬
|
| 1621 | Sunphenon EGCg TM | - | - | - | - | [1] 13 13 💬
|
| 1622 | Superficial skin swabs | - | - | - | - | [1] 160 160 💬
|
| 1623 | Suplatast | [1] Suplatast Suplatast | [1] Suplatast tosilate
Suplatast tosilate
💬
| - | - | [2] 85 85, 226 💬
|
| 1624 | Suplatast tosilate | [1] Suplatast Suplatast | [1] Suplatast tosilate
Suplatast tosilate
💬
| - | - | [1] 226 226 💬
|
| 1625 | Supplement nutritional supporting | - | - | - | - | [1] 291 291 💬
|
| 1626 | Supplemental oxygen via a mask | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 88 88 💬
|
| 1627 | Supplementary tubes | - | - | - | - | [1] 166 166 💬
|
| 1628 | Supplementation | - | - | - | - | [1] 6 6 💬
|
| 1629 | Supplementation with vitamin D2/D3 | - | - | - | - | [1] 299 299 💬
|
| 1630 | Supportive and immunosuppressive therapy | - | - | - | - | [1] 66 66 💬
|
| 1631 | Supportive therapy | - | - | - | - | [2] 66 66, 223 💬
|
| 1632 | Supportive therapy with: ACE-inhibitor / ARB / Statin | - | - | - | - | [1] 66 66 💬
|
| 1633 | Supressi. T-Diet plus Range | - | - | - | - | [1] 6 6 💬
|
| 1634 | Suramin | [1] Suramin Suramin | - | - | - | [1] 331 331 💬
|
| 1635 | Surgery | - | - | - | - | [1] 145 145 💬
|
| 1636 | Surgery for acromegaly | - | - | - | - | [1] 77 77 💬
|
| 1637 | Surgery to implant human CNS stem cells (HuCNS-SC) | - | - | - | - | [1] 19 19 💬
|
| 1638 | Surgery treatment | - | - | - | - | [1] 291 291 💬
|
| 1639 | Surgical ESPB | - | - | - | - | [1] 70 70 💬
|
| 1640 | Surgical Septal Myectomy | - | - | - | - | [1] 58 58 💬
|
| 1641 | Surovatamig | - | - | - | - | [3] 46 46, 49, 222 💬
|
| 1642 | Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide | - | - | - | - | [1] 3 3 💬
|
| 1643 | Susoctocog alfa | [1] Susoctocog alfa Susoctocog alfa | [1] Susoctocog alfa
Susoctocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 1644 | Susoctocog Alfa (Genetical Recombination) | [1] Susoctocog alfa Susoctocog alfa | [1] Susoctocog alfa
Susoctocog alfa
💬
| [1] F8 F8 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
| 1645 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1646 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1647 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1648 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1649 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1] 97 97 💬
|
| 1650 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 1651 | Suspension de microbiote fécal | - | - | - | - | [1] 97 97 💬
|
| 1652 | Suspension IR | - | - | - | - | [1] 46 46 💬
|
| 1653 | Suspension media | - | - | - | - | [1] 13 13 💬
|
| 1654 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 1655 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [2] 96 96, 97 💬
|
| 1656 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 💬
|
| 1657 | Suspension of human autologous MSC 3P in 1,5 ml | - | - | - | - | [1] 2 2 💬
|
| 1658 | Suspension of human autologous MSC 3P in 1.5 ml | - | - | - | - | [1] 2 2 💬
|
| 1659 | Sustained-release Carbidopa/Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1660 | Sustained-release oral dalfampridine | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬
| [7] KCNA1 KCNA1, KCNA2, KCNA4, KCNA6, KCNC3, KCND2, KCND3 💬
| [5] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 💬
|
| 1661 | Sustained-Release Tablets | - | - | - | - | [1] 11 11 💬
|
| 1662 | Sustanon (testosterone) | [1] Testosterone Testosterone | [1] Testosterone
Testosterone
💬
| [1] AR AR 💬
| [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 113 113 💬
|
| 1663 | Sustanon 250 | - | - | - | - | [1] 113 113 💬
|
| 1664 | SUSTIVA | - | - | - | - | [1] 265 265 💬
|
| 1665 | Sutent®/Sunitinib | [1] Sunitinib Sunitinib | [2] Sunitinib malate
Sunitinib malate
,
Sunitinib
💬
| [9] CSF1R CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬
| [38] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 34 34 💬
|
| 1666 | Sutimlimab | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬
| [1] C1S C1S 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬
|
| 1667 | Sutimlimab (BIVV009) | [1] Sutimlimab Sutimlimab | [1] Sutimlimab
Sutimlimab
💬
| [1] C1S C1S 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 💬
|
| 1668 | Suvecaltamide | [1] Suvecaltamide Suvecaltamide | [1] Suvecaltamide
Suvecaltamide
💬
| [3] CACNA1G CACNA1G, CACNA1H, CACNA1I 💬
| [8] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | [1] 6 6 💬
|
| 1669 | Suvodirsen | [1] Suvodirsen Suvodirsen | - | - | - | [1] 113 113 💬
|
| 1670 | Suvorexant | [1] Suvorexant Suvorexant | [1] Suvorexant
Suvorexant
💬
| [2] HCRTR1 HCRTR1, HCRTR2 💬
| [2] Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [3] 5 5, 6, 13 💬
|
| 1671 | SV001 | - | - | - | - | [1] 85 85 💬
|
| 1672 | SVG103 | - | - | - | - | [3] 136 136, 137, 158 💬
|
| 1673 | SVS20 | - | - | - | - | [1] 53 53 💬
|
| 1674 | Swallowed fluticasone | [1] Fluticasone Fluticasone | [1] Fluticasone
Fluticasone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 1675 | Sweet manioc starch | - | - | - | - | [1] 257 257 💬
|
| 1676 | Switch of anti TNF for ustekinumab for paradoxical psoriasis. | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 💬
|
| 1677 | Switch to Myfortic | - | - | - | - | [1] 49 49 💬
|
| 1678 | SXR1096 | - | - | - | - | [1] 160 160 💬
|
| 1679 | SXR1096 cream | - | - | - | - | [1] 160 160 💬
|
| 1680 | Syde | - | - | - | - | [1] 111 111 💬
|
| 1681 | SYH2053 Injection | - | - | - | - | [1] 79 79 💬
|
| 1682 | SYH2059 Tablets | - | - | - | - | [1] 85 85 💬
|
| 1683 | SYH2070 injection dose1 | - | - | - | - | [1] 79 79 💬
|
| 1684 | SYH2070 injection dose2 | - | - | - | - | [1] 79 79 💬
|
| 1685 | SYHX2008 | - | - | - | - | [1] 77 77 💬
|
| 1686 | SYHX2008 injection | - | - | - | - | [1] 77 77 💬
|
| 1687 | Sym001 | - | - | - | - | [1] 63 63 💬
|
| 1688 | Symbicort | - | - | - | - | [2] 85 85, 228 💬
|
| 1689 | Symbiotic Formula with DHA and antioxidants | - | - | - | - | [1] 299 299 💬
|
| 1690 | Symdeko | - | - | - | - | [1] 299 299 💬
|
| 1691 | Symkevi | - | - | - | - | [1] 299 299 💬
|
| 1692 | Symkevi 100mg/150mg Film-coated tablets | - | - | - | - | [1] 299 299 💬
|
| 1693 | Symkevi 100mg/150mg Film-coated tabletsProduct Code: VX-661 / VX-770Pharmaceutical Form: Film-coated tabletINN or Proposed INN: TEZACAFTORCAS Number: 1152311-62-0Current Sponsor code: VX-661Other descriptive name: TEZConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-INN or Proposed INN: IVACAFTORCAS Number: 873054-44-5Current Sponsor code: VX-770Other descriptive name: IVAConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useTrade Name: Kalydeco 150 mg film-coated tabletsProduct Code: VX-770Pharmaceutical Form: Film-coated tabletINN or Proposed INN: IVACAFTORCAS Number: 873054-44-5Current Sponsor code: IvacaftorOther descriptive name: IVAConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 150-Pharmaceutical f | - | - | - | - | [1] 299 299 💬
|
| 1694 | Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | [3] Aldosterone Aldosterone, Angiotensin II, Calcium | [4] Angiotensin II
Angiotensin II
,
Angiotensin II
,
Aldosterone
,
Angiotensin II acetate
💬
| [3] AGTR1 AGTR1, AGTR2, NR3C2 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1695 | Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil) | [3] Azathioprine Azathioprine, Mycophenolate mofetil, Tacrolimus | [6] Tacrolimus
Tacrolimus
,
Azathioprine
,
Mycophenolate mofetil
,
Azathioprine sodium
,
Mycophenolate mofetil hydrochloride
,
Tacrolimus
💬
| [7] IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [35] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 💬
|
| 1696 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | - | - | - | - | [1] 11 11 💬
|
| 1697 | Syn-One skin biopsy | - | - | - | - | [1] 6 6 💬
|
| 1698 | SYN115 | - | - | - | - | [1] 6 6 💬
|
| 1699 | SYN115 Tablets, 60 mg | - | - | - | - | [1] 6 6 💬
|
| 1700 | SYN120 | - | - | - | - | [1] 6 6 💬
|
| 1701 | Synacthen | - | - | - | - | [1] 78 78 💬
|
| 1702 | Synacthen (Tetracosactrin) | - | - | - | - | [1] 78 78 💬
|
| 1703 | Synacthen Ampoules 250 mcg | - | - | - | - | [1] 113 113 💬
|
| 1704 | Synacthen Ampoules 250 microgrammi | - | - | - | - | [1] 113 113 💬
|
| 1705 | Synacthen Depot | - | - | - | - | [2] 83 83, 145 💬
|
| 1706 | Synacthen Depot 1mg | - | - | - | - | [1] 222 222 💬
|
| 1707 | SYNB1020 | [1] SYNB1020 SYNB1020 | - | - | - | [1] 251 251 💬
|
| 1708 | SYNB1353 | [1] SYNB1353 SYNB1353 | - | - | - | [1] 337 337 💬
|
| 1709 | SYNB1618 | - | - | - | - | [1] 240 240 💬
|
| 1710 | SYNB1934 | - | - | - | - | [1] 240 240 💬
|
| 1711 | SYNB1934v1 | - | - | - | - | [1] 240 240 💬
|
| 1712 | Synbiotic | - | - | - | - | [2] 49 49, 96 💬
|
| 1713 | Synbiotic (Synergy I / B.longum) | - | - | - | - | [1] 96 96 💬
|
| 1714 | SYNCAR-001 | - | - | - | - | [2] 49 49, 51 💬
|
| 1715 | Synergy | - | - | - | - | [1] 240 240 💬
|
| 1716 | Synergy-1 | - | - | - | - | [1] 97 97 💬
|
| 1717 | Synergy1 | - | - | - | - | [1] 97 97 💬
|
| 1718 | Syngeneic Bone Marrow Transplantation | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 1719 | Synovial biopsy | - | - | - | - | [1] 46 46 💬
|
| 1720 | Synovial tissue | - | - | - | - | [1] 46 46 💬
|
| 1721 | Synrinse | - | - | - | - | [1] 299 299 💬
|
| 1722 | SYNT001 | - | - | - | - | [1] 61 61 💬
|
| 1723 | Synthetic 15-amino-acid macrocyclic peptide | - | - | - | - | [1] 62 62 💬
|
| 1724 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 | - | - | - | - | [1] 62 62 💬
|
| 1725 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker | - | - | - | - | [1] 62 62 💬
|
| 1726 | Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker | - | - | - | - | [1] 62 62 💬
|
| 1727 | Synthetic DMARD(s) | - | - | - | - | [1] 46 46 💬
|
| 1728 | Synthetic Human Parathyroid Hormone 1-34 | [1] Parathyroid hormone Parathyroid hormone | [1] Parathyroid hormone
Parathyroid hormone
💬
| [2] PTH1R PTH1R, PTH2R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 1729 | Synthetic Oxytocin | [1] Oxytocin Oxytocin | [1] Oxytocin
Oxytocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1730 | Synthetic PreImplantation Factor | [1] Preimplantation factor Preimplantation factor | - | - | - | [1] 95 95 💬
|
| 1731 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | [2] 2 2, 127 💬
|
| 1732 | Syntocinon | - | - | - | - | [2] 127 127, 193 💬
|
| 1733 | Syntocinon 40 IU/ml nasal spray | - | - | - | - | [1] 6 6 💬
|
| 1734 | Syntocinon nasal spray | - | - | - | - | [1] 193 193 💬
|
| 1735 | Syntocinon®/- Spray | - | - | - | - | [1] 193 193 💬
|
| 1736 | Syringe Front-Loading Device | - | - | - | - | [1] 6 6 💬
|
| 1737 | SYS6020 | - | - | - | - | [1] 49 49 💬
|
| 1738 | SYS6020 injection | - | - | - | - | [1] 11 11 💬
|
| 1739 | Systane Ultra UD | - | - | - | - | [1] 53 53 💬
|
| 1740 | SYSTANE™ Hydration Lubricant Eye Drops | - | - | - | - | [1] 46 46 💬
|
| 1741 | Systematic chemotherapy and antibodies | - | - | - | - | [1] 62 62 💬
|
| 1742 | Systemic anticoagulation | - | - | - | - | [1] 88 88 💬
|
| 1743 | Systemic chemotherapy and antibodies | - | - | - | - | [2] 62 62, 326 💬
|
| 1744 | Systemic corticosteroids | - | - | - | - | [1] 271 271 💬
|
| 1745 | Systemic non-biological treatments | - | - | - | - | [2] 46 46, 271 💬
|
| 1746 | Sübetaholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬
|
| 1747 | Süßholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 💬
|